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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
      “Siddha system of medicine” is a form of a traditional medicine system which 
originated down south.Siddha means achievment, which was attained by siddhars. 
They were saints who were mystics and are credited for developing and forwarding 
the system of Siddha medicine.It is believed that there were eighteen Siddhars in total, 
who are also referred to as the enlightened souls. 
     The Siddha system is largely therapeutic in nature and its origin can be traced back 
to the birth of human race on the planet.According to mythological and historical 
beliefs,the initial home of mankind was located in the temperate and fertile regions of 
the east.The human race started its culture and career from here. 
     Moreover this wondrous land was primarily inhabited by the Dravidians of whom 
the Tamilians where the most prominent.They were also accredited for being one of 
the most developed civilizations which ever dwelled upon this planet. 
     Dravidian language was predominent in southa. Siddha was flourishing in the 
south owing to its antiquity, the origin of this system is attributed to the creator 
himself as per traditional tales,it is deamed that lord Shiva unfolded the knowledge 
about Siddha   Neverthless, saint Agasthiyar is accredited for founding the Siddha 
system of medicine. His works on medicine and surgery, still serve as standards 
among Siddha medical parctitioners. 
    According to the ancient Siddha texts, a human body is made up of several 
elements. It is a microscopic component of the universe. The elements that form a 
human body are the earth (Munn), fire (Akasam), Additionally there are three 
HUMORS  called the Vatham pitham and kabam. Siddha medicine believes that 
diseases occur when there is a disequilibrium or imbalance in these humors or if their 
individual hormony is disturbed. 
    Pitha diseases occurs when Pitham gets dearanged due to the activities of humans 
and it exposed with burning sensations, aggressiveness, and fatigue. 
     According to “YUGI VAIDHYA CHINATHA MANI – 800” Diseases of Pitham 
are classififed into 42 types. This classification provides symptoms of “Uratha 
pitham” more or less similar to Hypertension. 
Drug Name: “Pudhina theeneer”. 
Reference: Sigicharathnadeepam 
     The drug Pudhina theeneer relieve the symptoms of giddiness, tiredness and 
reduction in High blood pressure and cholesterol. 
    The balance can be restored by correcting the underlying dosha by the application 
of the Siddha medicine system. 
    The three humors co-exist in all the cells of the body. They function in a 
harmonious manner to create a balance. 
    The three humors are considered the three pillars of health and support the structure 
and functions of the body. These humors are involved in regulating all the functions 
of the body, and maintain the balance in the physical emotional and mental spheres. 
     Hypertension is the commonest cardiovascular disorder, posing a major public 
health challenge to population in socioeconomic and epidemiological transtition. It is 
one of the major risk factor for cardiovascular mortality, which accounts are 20-50%  
of all deaths. 
     Globally the overaall prevalence of raised blood pressure in adult aged 25 and over 
was around 40% in 2008. 
    The proportion of the worlds population with high blood pressure or uncontrolled 
hypertension fell modestly between 1980 and 2008. However because of population 
growth and ageing the number of people with uncontrolled hypertension rose from 
600 million in 1980 to nearly 1 billion in 2008. 
     Across the income groups of countires, the prevalence of raised blood pressure was 
consistently high, with low, lower middle and upper middle countries all having rates 
of around 40% the prevalence in high income countries was lower, at 35%. 
    I have choosen “Pudhina theeneer” as my dissertation work for uratha pitham 
which correlates with hypertension as described in the modern medical system. 
   “Pudhina theeneer” will be an effective as well as  Safety herbal  drug in the 
treatment of Hypertension. 
  
 
AIM AND OBJECTIVES 
 
 
 
 
 
AIM AND OBJECTIVE 
AIM: 
The purpose of this study is evaluate the safety and efficacy of Siddha herbal 
formulation of “PUDHINA THEENEER” in the treatment of Uratha pitham. 
OBJECTIVES: 
 Collections of various Siddha literature of the study. 
 Herbal Identification and authentication of the trial drug. 
 To prepare the trial drug “PUDHINA THEENEER”as per standard operative 
procedures drug preparation. 
 To evaluate the Biochemical,Anti-microbial&physio-chemical analysis of the 
drug. 
 To evaluate the safety profile like acute toxicity,sub acute toxicity of the trial 
in animal models as per OECD guidelines. 
 To evaluate the pharmacological analysis of ANTI HYPERTENSIVE 
ACTIVITY for  my  trial  drug. 
 To correlate the Siddha diagnostic parameters by 
Mukkutram,Udalthathukkal,Uyirthathukkal and Envagai thervugal. 
 To use modern parameters to confirm the diagnosis and prognosis of the 
disease. 
 To make a clinical observation about the disease in relation of age, sex, 
occupation, social economic status, diet ,and family history. 
 The haematological analysis,urine analysis,radiological studies will be done to 
all patients. 
 To find out the statistical analysis and efficacy of the trail drug through 
clinical study. 
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 REVIEW OF LITERATURE 
SIDDHA ASPECTS: 
According to Yugi Vaidhya Chinthamani. 
 
kfpo;e;JNk gpj;je;jhd; tUFk; thW 
krNjtHjikg;gzpakhl;lhjhHf;Fk; 
kfpo;e;JNkFUtbiatzq;fhjhHf;Fk; 
khjhtpd; kdkfpohkhHf;fj; jhHf;Fk; 
kfpo;e;Juptjputpaj;ijagfhpj; NjhHf;Fk; 
khghjfHf;Fte;JkUTk; ghNu 
kUTNkGspg;Gciug;Gyg;GkpQ;ry; 
kdjpNyJf;fq;fsiljyhY 
neUTNkneUg;Gnta;apy; Nfhge; jd;dpy; 
epj;jpiujhdpy;yhdhy; tpUj;jpUf;fpy; 
mUTNkmf;fpdpapw; nghrpf;ftpl;lhy; 
mjpfkha;g; ngz;NghfkDgtpj;j 
eUTNkehbf;Fk; NkNyepd;W 
ehbNafz;lkl;lhapUf;Fk; ghNu 
                                             -  Yugi vaithya chinthamani10 
 
 
• Persons do not pay respect to God. 
• Persons who do not give due respect to guru. 
• Persons who do not respect to Mother. 
• High intake of sour and salt foods. 
• Having  mourning in mind. 
• Walking in sunlight and heat. 
• Insomnia. 
• Excessive indulgence in sex. 
       The disease taken here is ‘Uratha Pitham’ is mentioned under Yugimuni’s    
classification of Pitha diseases. Disease  of pitham are of 42 types in his classification. 
 Pitha Noigal:- 
Other Name :- Azhal Noigal. 
Definition:- 
     Pitha diseases occurs when  Pitham gets deranged due to the activities of humans 
and it exposed with burning sensations, aggressiveness, difficulties in conversion 
processes of the body and Imbalance in the energy and heat producing capacities. 
Classification of pitha diseases:- 
According to Yugi vaidhya chinthamani. 
     Diseases of Pitham are classification into 42 type. This classification provides 
Symptoms of Urathapitham more or less similar to Hypertension. 
Quote Says. 
“ehl;bNdd; gpj;jj;jpd; ngaiuj;jhDk; 
ehw;gj;jpuz;lhdFzhFzq;fs;” 
                                                                   - Yugimuni  Vaithya chinthamani.6 
According to Pararasasekaram. 
The Pitha diseases are classified upto 40 types in Pararasekaram. 
“tw;wpLq; fhrgpj;jNkhjpathjgpj;jk; 
nfhw;wpLk; twl;rpgpj;je; JaUWRow;Wgpj;jk; 
nrw;wpLQ; rj;jpgpj;jQ; Nrw;gdgpj;je; Njfk; 
tw;wpLKyHe;Jgpj;jk; trkwg; gpjw;Wk; gpj;jk; 
gpj;jkhnaLf;Fk; gpj;jk; Njjpj;JeLf;Fk; gpj;jk; 
rj;jkhkTdgpj;je; JaUwNthLk; gpj;jk; 
rj;jkhHfbagpj;jQ; rhw;wpathAg; gpj;jk; 
rpj;jkhAwq;Fk; gpj;jk; nrk;gpj;jQ; rPjgpj;jk; 
Ngjkhayl;Lk; gpj;jk; ngUj;JthA+Wk; gpj;jk; 
VjkhNaWk; gpj;japyq;Fe; juj;jpw; gpj;jk; 
fghy khH G+jgpj;jk; gUk;gpj;j KNuhfgpj;jk; 
mghakhHujpfgpj;jkLk;gpj;jkNuhrpgpj;jk; 
xUjdptplhjgpj;jNkhjpLk; tprhpd; gpj;jk; 
jUktpfhagpj;jQ; rhHrapj;jpaj;jpd; gpj;jk; 
cdUkpF ke;j gpj;jNkhjpd kpdpNkypg;ghy; 
tUkjpd; FzKQ; nra;atpFj;jpL kUe;JQ; nrhy;Nthk;” 
                                                                         
                                  - Pararasasekaram 11 
                                                                                                                      
According to sadhagaNaadi. 
cWjpAs;sgpj;jkJNjhd;wpy; ntg;G 
   c\zthAtj;jpuRukjprhuq;fs; 
kwjpAld; fpWfpWg;Ggapj;jpaNuhfk; 
   tsHNrhifaonyhpTfhe;jy; ifg;G 
,Ujaj;jpy; fyf;fkJkwg;Gjhfk; 
   vOq;fdTNkaidTkaf;f %Hr;ir 
rpwpJngUk; ghLuj;jk; gpuNkfq;fs; 
   NrHe;JkpFgpzpgyTQ; rpwf;Fe; jhNd. 
                                                                    -  Noi naadal noi muthal naadal thiratu12 
This verse says. 
• Diarrhoea 
• Heat, Fever 
• Loss of Memory 
• Giddiness 
• Fatigue 
• Anaemia 
• Burning sensation 
• Bitter in taste 
• Hallucination 
• Mild menorrhagia 
• Discharge of fluid with blood 
• Palpitation 
 
 
According to Danvandhiri Vaidhiyam. 
“mfhyepj;jpiuapdhYk; mjprq;fNkhfj;jhYk; 
jfhjntk; grpapdhYk; jUtplNkw;ifahYk; 
gfhjtd; fpkyrj;jYk; gapj;jpagjhHj;jj;jhYk; 
rpfujhq; fy;ifahYe;jNrHe;jpLk; gpj;je; jhNd” 
 
“,Ukyklf; ifahYk; nkhUkykpiof; ifahYk; 
tUk; ntapy; ngUf;ifahYkdKWNfhgj;jhYQ; 
RukJjhpf;ifahYQ; RLgpzehw;wj;jhYe; 
jputpaq; nfL ifahYQ; NrHe;jpLk; gpj;je; jhNd” 
                                                                                        -  Danvadhiri vaidhiyam18 
 
This  Verse, Says 
• Irregular sleeping habit 
• Increased appetitate 
• Lust on women 
• Excessive intake of foods that increase pitham 
• By the ill effects of sun’s rays 
• Angry 
• Fever 
• Not properly intake of drug( Diraviyam). 
According to pararasasekaram, 
“nta;apypilf;ifahYk; ntk;grpkpFj;jyhYk; 
Ja;aNjhy; uYnua; ahd;ghy; Ja;j;jiytpLj;jyhYk; 
ieaNttUq;Nfhgj;ijez;nzahw; frg;igehSk; 
ifAwcz;zyhYq; fjpj;jpLk; gpj;jNjh\k;” 
 
“gpj;jj;ijtpisf;Fnkd;WNgrpaTzitehSk; 
Nkj;jNtaUe;jyhYkpFe;jpLk; Jauj; jhYk; 
epj;jiuapyhik ahY epidTfz; kpFj;jyhYk; 
kw;WsNtJthYk; thj;jpf;Fk; gpj;jNjh\k;” 
                                                                                        -Pararasasekaram14 
  
This verse says the aetiological factors that, lead to Pitha diseases. 
These are 
• Walking in sunlight 
• Excessive appetite 
• Avoiding intake of milk and ghee 
• Increasing anger 
• Excessive intake of sour foods 
• High intake of food which increase pitham 
• Loss of sleep 
 
PITHAM 
      Pitham is one among the three humours, VIZ Vatham, pitham and kabam. These 
three humours are together known as “Muthathukkal” 
“epyk; ePHjPtsptpRk;Nghile;Jk; 
fye;jkaf; fKyfk; Mjypd;” 
                                                        -Sadhaga naadi Noi naadal noi muthal naadal15 
“jyq;fhl;b ,e;jr; rlkhditk;G+jk; 
epyq;fhl;b ePHfhl;b epd;wpLw; jP fhl;b 
tyq;fhl;bthAthy; tsHe;Nj ,Ue;j 
Fyq;fhl;bthdpw; FbahapUe;jNjh” 
                                                      - Noi naadal noi mudhal naadal32 
 
The above said five elements called as “Pancha Boodham” are, 
Prithivi - Earth 
Appu  - Water 
Theyu   - Fire 
 Vayu  - Air 
Aahayam - Space. 
      Thus Vayu and Aahayam combine to become vatha uyir thathu, which controls all 
aspects of movements. The words dry, light, cold, quick, rough minute and mobile 
describe the characteristics fo  ‘Vatha Yuir thathu. 
     Theyu alone becomes  Pitha uyir thathu which controls all the body’s conversion 
processes, produce heat and energy producing capacities. The words hot, pungent, 
aggressive, Liquid, mobile and acid describe the characteristics, of Pitha uyir thathu. 
       Appu supported by Prithivi becomes Kabha uyir thathu and controls  lubrication 
and cohesion. It is also responsible for giving solidity and structure to the body. 
Kabha Uyirthathu primarily reflects the qualities of the water but also some traits of 
the earth element, consequently kabha is heavy, slow, cold, steady, solid and oily. 
 
FORMATION OF MUTHODAM 
MfkJ ehb euk;G naOgj;jPuhapk; 
,Ug;gh ehb VOg NhNuh 
apukhd Njfj;jpy; fyg;Ng ehb 
Vf;fr; rkj; njhopy; Cf;f rfthA 
jf;f ehb vd;Nw rhL 
                                                                  -Yugi Vaidhya Chindhamani44 
 
,Ug;ghd ehb VOgNjhBuh 
apukhd Njfjj;py; Vyg; ngUehb 
xf;fjrkj; njhopiy Cf;f jr thAf;fs; 
jf;fgb vd;Nw rhUk; 
rhUe;jr ehb jd;dpy; %yk; %d;W 
NgUkplk; gpq;fiyAk; gpd;dYld; - khWk; 
ciuf;ftpuw; fhw;nwhl;Ldj;JNk ehrp 
tiur RopNah ikaj;jpy; 
te;J fiy %d;wpy; thAthk ghdDld; 
je;j gpuhzd; rkhdDf;FQ; re;jkwf; 
$l;LwT Nufpj;jy; cWk; thjk; gpj;jk; 
ehl;Lq; fgNkahk; ehL” 
                                                                                  -Kannusamiyam43 
       According to this verse the human body is composed of 72,000 Naadi 
narambugal 
      Among this 72,000 Naadies ten are prominent Naadies (Dasa Naadies).  Of these 
ten Naadies 3 are known as Moolathara Naadies 
These are 
1. Edagalai 
2. Pingalai 
3. Suzhumunai 
Ten Vayus present in the body are 
1. Piranan 
2. Abhaanan 
3. Udhanan 
4. Viyanan 
5. Samanan 
6. Nagan 
7. Koorman 
8. Kirugaran 
9. Devathathan 
10. Thananjeyan 
 
 
        Among these Abhaanan conjugates with Edagalai to form  ‘Vatham’ 
Piranan conjugates with Pingalai to form  ‘Pitham’ 
Samanan conjugates with Suzhumunai to form  ‘Kabam’ 
       These three humours Vatha, Pitha and Kabha are more or less correlated with 
excreta, Gastric juice, and saliva respectively 
        They circulate in the body system in different proportions and help in the 
digestion of food and other general physiological functions of the body. Each of them 
has different functions. 
      The right proportion of each in proper combination are responsible for 
maintaining the good health. 
       When some of the environmental factors like diet, weather etc., disturb Pitha, it 
looses its control, which may be diminished or exaggerated. So the other  two  Uyir 
thathus are also disturbed which are in peculiar equilibrium state. Finally this may 
leads to Pitha diseases. 
Natural Characteristics of Pitham 
Locations 
Generally Pitham  lives  in 
1. Piranan 
2. Pingalai 
3. Head 
4. Heart 
5. Blood 
6. Stomach 
7. Urinary bladder 
8. Sweat 
9. Eye 
10. Skin 
11. Umblicus 
12. Saliva 
 According to THIRUMOOLAR 
          gphpe;jpLk; gpj;jk; NuhQ;ryj;jpdpy; 
means pitha lives in urine 
According to Yugi muni 
Nghnkd;w gpj;jj;Jf; fpUg;gplNk Nfsha; 
Nguhd fz;lj;jpd; fPojhFk; 
It means, place of the  ‘Pitham’  in body is below the neck. 
NATURAL PROPERTIES 
Pitham in its natural habit may cause 
 Digestion 
 Hunger or Hungry (Poly phagia) 
 Taste 
 Thirst 
 Vision 
 Light 
 Concentration 
 Knowledge 
 Softness 
 Warm 
 Hardness 
 Heat Production in the body 
 Bluish colour formation 
 Production of heat during digestion 
 Memory power 
 
       After having said so much about the description of Dathu and“Thiridathu” or 
“Thiridosham” according to Siddha system of Medicine. 
Here, Pitham is the third one relocated to fire, 
     Fire makes the form of the body steady and gives vigour and stimulation. Digestion 
and circulation represent it in the body. 
    Like here Vatha, Pitha and Kapha, have multiple significance and are symbolical in 
terms. 
    Pitham represents gastric juice, bile, energy, heat, inflammation, anger and 
irritation etc., 
   Here the description is anatomical and physiotopical and each has been described in 
five forms with five functions. 
 
Five forms of Pitha. 
 Gastric juice (Analaga pitham ) – This give appetite and helps digestion. 
 Bile (Prasagam) – which gives completion to the skin. 
 Haemoglobin (Ranjagam) – which colours the blood. 
 Aqueoces Humour (Alosagam) – which brightens the eyes. 
 Life energy (Sadhagapitham) – which controls the whole body. 
 
 
Qualities of Pitham 
Own qualities. 
Akkini - Hot 
Pulippu - Acidity 
Odum thanmai- Mobility 
Salaroopam   - Liquidity 
Kaaram         - Pungent 
Kurooram    - Agressiveness 
 
Opposite qualities 
Kulirchi - Cold 
Inippu - Sweet 
Nilaithiruthal - Immobility 
Kasappu - Bitter 
Saantham - Mild  or Harmless. 
Getti  - Solidity. 
From this to 
Natural characteristics of Pitham Locations 
Generally, Pitham lives in 
 Piranan 
 Pingalai 
 Head 
 Heart 
 Blood 
 
Hyper  Pitha  - Signs 
 Yellowish discolouration of eye, skin urine and motion 
 Poly phagia and poly dypsia 
 Burning sensation all over the body 
 Sweating 
 Giddiness 
 Haemorrhage 
 Angry 
 Immovable 
 Emaciation 
 All taste to be like sour or bitter 
 
Hypo  Pitha  - Signs 
 Cold 
 Decrease  in  colour 
 Disturbance  in natural growth of  Iyam 
 Less  heat 
 
Characterestics  Pitha Thegi -  Natural 
Physical characters 
 The person has high thee thoda 
 The muscle content can be less beyond the bones and joints 
 Body may appear always with heat, sweating and with unpleasent smell 
 Wrinkled skin 
 Colour of the skin can be yellowish red with shining 
 Face, palm and sole are reddish yellow in colour 
 Thin eyelids 
 Reddish discoluration of eyes due to heat, anger and hungry. 
 Slighly yellowish hair 
 Fewer hair in the body and grey 
 Black moles with pimples 
 More heat in the body 
 Yellow or red colur of the body 
 Reddishness in upper and Lower limbs 
 Lesser hair in body 
 Giddiness 
 
 
Behavioural  characters 
 Willing to take sweet, Astringent, Bitter and cold foods 
 Lesser intake of food 
 Intolerence to appetite, thirst, heat, angry and fear 
 Willing to be garlanded 
 Oligospermia 
 Low   kaamam 
 Reduced   lust 
 Hatefullness, respect, courge, clear knowledge, talkative, good habits, 
discipline and love with others 
 In dream there will be sun, wind, light of fire, lightening and kongu tree with 
flowers, caeasalpenia tree (Sarakkondrai) Murukkan tree are found 
 Happier  and  has  good  eduction 
 Age will be  65 years and has 3/4 vitality 
 Higher appetite 
 Intolerence  to thirst 
 Courage 
 Good knowledge 
 More appetitate 
 
 
 
Pitha thega kuri 
mwpthd gpj;jj;jhnyLj;j Njfk; 
awnkypT epwk; nts;is ahpitNahL 
gphpahj RfyPiyaw;g Tz;b 
ngUk;Gspg; GzT nfhs;sy; nghpNahh; jk;ik 
Fwpahj thrhuk; gz;zy; Gj;jp 
Fok;gpg; gpd; Njwy; fiyf; Qhd Nghjk; 
newpahff; fw;wwpT nrhy;yy; tPuk; 
epiyg;G kjpapy; f;fkjp awtkhNk 
                                                                                 -Noi Naadal noi mudhal naadal15 
 
According to this verse, the natural characteristics of Pitha thegi are 
 Emaciation 
 White coloured skin 
 Low intake of food 
 Willing to take sour taste foods 
 Confused minds 
 Interest in Arts 
 Respect to elders 
 Intelligency 
 Courage 
 Excessive lust 
 
Place and function of Pitham 
jhdhd gpj;jk; gpq;fiyiag; gw;wpr; 
rha;thd gpuhz thAT jd;idr; nrh;e;J 
Cdhd ePh;g;igapy; mZfp  %yj; 
Jjpj;njOe;j tf;fpdpia cwT nra;J 
khNd NfspUjaj;jpypUg;G khfp 
kayhfp epidthfp kaf;fkhfp 
fhdhd rpue;jdpNy ,uf;fkhfpf; 
nfhz;L epd;w gpj;jepiy $wpNdhNk 
                                                                               -Noinaadal Noi Mudhal Naadal23 
 
      According to this verse, Pitham is associated with Piranan and Pingalai, goes to 
urinary  bladder and  mix with  Seevakkini  to lives in heart and head. 
 
SYMPTOMS DUE TO EXCESS IN PITHAM 
cWjpAs;s gpj;jkJ Njhd;wpy; ntg;G 
cl;zthAtj;jp Rukjp rhuhq;fs; 
kwjpAld; fpWfpWg;G gapj;jpa Nuhfk; 
tsh; Nrhif aonyhpT fhe;jy; ifg;G 
,Ujaj;jpy; fyf;fkJ kwg;G jhfk; 
vOq;fdT NkaidT kaf;f %h;r;ir 
rpwpJ ngUk;ghL uj;jk; gpuNkfq;fs; 
Nrh;e;J kpF gpzp gyTQ; rpwf;Fe; jhNd 
                                                                                  -Sadhaga Naadi37 
 
 
According to this  verse , the  symptoms due to excess in pitham  are 
 Excess heat 
 Fever 
 Dysentry 
 Loss of memory 
 Giddiness 
 Mental disorders 
 Dropsy, burning 
 Fear in heart, thirst, dreams 
 Loss of consciousness 
 Menorrhogia 
 Gonorrhoea 
 
gpj;jNk nrdpj;jhw; R+L 
ngyj;Jl Yyur; nra;Ak; 
gpj;jNk kpFe;jhyPis 
apUkYk; ngyj;J epw;Fk; 
gpj;jNk kpFe;j jhdhy; 
ngyq; Fiwe;Jk; gOj;Jk; 
gpj;jNk jpul;bE}ypw; 
Ngrpdhh; nghpNahh; jhNk 
                                                             -Agathiar guna vaagada Naadi39 
Gpj;jNk fjpj;j NghJ ngUe;jpLk; thjKz;lhk; 
gpj;jNk fjpj;j NghJ ngUe;jpLk; gapw;wpy; thA 
gpj;jNk fjpj;j NghJ gpjw;wpLk; gpj;Nj NfS 
gpj;jNk fjpj;j NghJ gpwe;jpLk; gpzpaNdfk;. 
                                                                -Agathiar gunaVaagada Naadi40 
According to this verse the excess in Pitham may cause symptoms as follows 
 Increase in heat leads to dryness of body 
 Cough and tuberculosis 
 Loss of strength 
 Increase in Vatha 
 Excess gas in abdomen 
 Unwanted talkativeness 
 A state of delirium 
 
gFj;jpbw; gpj;jk; gygy rpe;ijahk; 
tUj;jpLk; the;jpAk; tha; ePh;kpf T+Wk; 
kFj;jpL Nkdpapy; khl;b vhpg;NgWk; 
kpFe;j td;dpf;F kpf tplq;iff;FNk 
                                                                                        -Thirumoolar 
According to this verse the symptoms due to excess in pitha are 
 Many thinkings 
 Vomiting 
 Excess secretion of saliva 
 Burning sensation in body 
 Bitter taste in tongue 
 
$wplNt tpj;jkJ kPwpw;whdhy; 
nfhLq;fhj;j Yl yow;rp eLf;f Kz;lhk; 
kPwplNt Nuhrpae;jhd; ehtwl;rp 
Nkyhd NrhgkJ; tpf;fy; %h;r;ir 
J}wplNt  fpW fpWg;G fhjilg;G 
njhe;jkhq; frg;GlNd kz;ilf; Fj;J 
MNk jhd; aj;jp Ruk; ghz;L Nrhif 
Mlhd tplhr; RuKk; gpuNkfe;jhd; 
NghNkjhd; fhkhiy gpj;j ntl;il 
nghy;yhj ghz;LlNd rpte;j ePuhk; 
NjfNk jhd; rptg;ghA kQ;rshAQ; 
rpW rpWj;JapUz;L tUq;Fop tpOe;J 
ehNk jhd; nrhd;NdhNk gpj;jf; $W 
etpd; wpl;ghh; thrKdp etpd; wpl;lhNu 
                                                                                -Agathiyar42 
 
 
In  these  verse  Agathiyar says  the  symptoms  of  excess  Pitham  are  the  follows: 
 Heat 
 Allergy 
 Shivering 
 Dryness of tongue 
 Dropsy 
 Hiccough 
 Loss of consciousness 
 Giddiness 
 Hearing loss 
 Bitter taste in tongue, Headache 
 Fever, Continuous fever 
 Oedema, Anaemia 
 Jaundice 
 Leucorrhoea 
 Red coloured urine 
 Red or yellow coloured skin 
 Emaciation 
 
           Vytha; Foyha; gpj;jQ; nra;Fzk; tpsk;gf; Nfsha; 
Nfhy Nty; tpop rpte;J Fsph;e;jpbhpUf;F ky;yhy; 
rPyNt ePh; fLj;J nehe;J RWfnfdr;rp te;J tPOk; 
QhyNk fpWfpnwd;W ehTyh;e;jpUf;Fq; fhNz 
                                                                           -Agathiarvaithyarathinachurukka naadi41 
 
According to this verse, the excess in Pitha cause the following symptoms 
 Reddish discolouration and feverishness 
 Burning micturition with pain and pricking 
 Giddiness 
 Dryness of tongue 
gpj;jj;jpy; gpj;jkhfpy; gpjw;wpLq; fpWfpWf;Fk; 
rj;jpAkjpf khFQ; rhPuj;jpisg; Gz;lhf;Fk; 
mj;jpahAyUNkdp ahfKk; NwjhFk; 
tw;wpNantSj;Jf; fhak; ntwz;L gpd; tPf;fKz;lhk; 
                                                                             -Agathiyargunavagada Naadi39 
 
According to this verse, the excessin pitha may cause the symptoms 
 Unwanted  talking 
 Giddiness 
 Vomiting 
 Breathlessness 
 Dryness of body 
 Paleness  an d oedema  of  body  can  occur 
 
 
jhndd;w gpj;j kPwy; rlnky;yhq; fhe;jy; fhZk; 
Cndd;w the;jp tha; eP&wpNa XOFQ; rhthd; 
thndd;w kl;by; ntFkz;ilapy; Fj;Jz;lhFk; 
Njndd;w tpf;fy; %h;r;ir nrtpailg;Gz;lhk; ghNu 
                                                                                          -Agathiar guna vagada Naadi40 
 
According to this verse the excess ion pitha may cause the symptoms such as 
 Burning sensation  all  over  the  body 
 Vomiting 
 Excess secretion   o f Saliva 
 Pricking  pain  in head 
 Hiccough 
 Unconsciousness 
 Loss   of   hearing 
 Death 
 
Relation with taste 
Taste, in  common  is  divided  into  6  types,  called  as   Aru Suvai (6 taste) 
Those are 
1. Inippu - Sweet 
2. Pulippu - Sour 
3. Uppu  -         Salt 
4. Kaippu - Bitter 
5. Kaarppu - Pungent 
6. Thuvarppu - Astringent 
     All  6  tastes  are  formed  by  the  combination  of  two  Boothams  from Pancha  
bootham, These are 
Inippu         = Prithivi + Appu 
Pulippu       = Prithivi + Theyu 
Uppu        =  Appu + Theyu 
Kaippu        = Vayu   + Aahaayam 
Kaarpu        = Vayu + Theyu 
Thuvarppu  =  Prithivi + Vayu 
 
     Like that in Mukkutra, Except Azhal, the other two kutra (vali, Iyam) has the 
combination of two Boothams. Azhal is formed by one Bootha that  is 
Vali =  Vayu  +  Aahaayam 
Azhal = Thee  or  Theyu 
Iyam  = Appu  +  Prithivi 
 
      From this we know that the knowledge about the combination of Boothas in the 
formation of Suvai and Mukkutra is very helpful to know that which taste has 
increased or neutralized the Mukkutra and to give treatment depending upon this 
     For example in case of Pitha diseases the taste, sour will become increased .  So 
that to neutralize Pitha we have to give the opposite tastes. 
Tastes that increase the Pitham 
GspJth; tpQ;Rq;fwp ahw;G+hpf;Fk; thjk; 
xsp Ath;ifg; Ngwpy; gpj;Jr; rPWk; fpspnkhopNa 
fhh;g;lgpdpg;G tpQ;rpw; fgk;tpQ;R Q;rl;bujr; 
Nrug; Gzh; NehaZfhNj 
                                                                  -Kannu Samiyam43 
 
According to this verse, bitter and salt tastes increase the Pitham 
Tastes that neutralize the Pitham 
gpj;jkjp fhpg;gpd; NgRk;ghpfhuk; 
Rj;jj; JtnuhL nrhy;ypdpg;Gr;  - rj;jhFk; 
ifg;Gr; RitNa fUJtjd; tPW 
va;g;gilA nkd;Wiuj;jh hpq;F 
                                                          -Kannu Samiyam43 
 
        According  to  this verse the tastes  which  neutralize  the  Pitham  are sweet  
astringent  and  bitter 
Three phases ‘PRAPAKAM’ metabolism 
Prabak 
metabolism 
Thodam  Taste Function 
Inippu Kabham  Sweet Moistering the 
food 
 
Pulippu 
    
Pitham  Sour Conversion of 
food into an 
absorbable form 
Kaarpu Vatham  Pungent Absorption and 
separation of food 
 
ALTERATIONS OF PITHAM 
      The three humours are affected either themselves or with Udal thaathukkal, 
pathologically 
 
 
The types of alteration of Pitham 
Thannilai Valarchi 
Definition   :  A Kutram which is provoked in its own  location is called thannilai 
valarchi 
Limitation  :  Hate  - fullness of the things which are causing thannilai valarchi and 
likeness of the things which are getting opposite properties are the limitations of 
thannilai valarchi. 
Period    :  Pitham gets thannilai valarchi during  “ Kaar Kaalam”   - Aavani and 
purattasi 
 
II. Vetrunilai   Valarchi 
Definition :    A  kutram  which  is  provoked  to  other  locations  is  called ‘ 
Vetrunilai valarchi’ 
Limitation :   Signs  and  Symptoms  of  the  affected   kutram  and  the  pathological 
conditions  of  the udal  thaathukkal give  the  details  of  the  limitatinos 
Period :   Pitham  gets  Vetrunilai  valarchi  during  koothir kaalam  Iyppasi  and  
Kaarthigai 
III. Thannilai Adiadhal 
Definition :   A  provoked  kutram,  which  is  neutralized  in  its  own  location  is  
called Thannilai  Adaidhal 
Period :  The  provoked   Pitha  neutralizes  during   Mun  Pani  Kaalam  Margazhi  
and  Thai. 
Types of Pitham 
      The Siddha classical texts divide Pitham into five subsidiary forms that differ 
from one another  by their localization in the body  (Anatomical and by their 
particular functinos  (Physiological) 
They are 
1. Anal Pitham 
2. Eranjagam 
3. Saadhagam 
4. Aalosgam 
5. Prasagam 
 
 
Anal Pitham 
       This give appetite and helps in digestion. It has the character of thee or fire.  It 
lies between abdomen and scrotum. Pitham dries the liquid form things and digests 
the food we take. 
 
Eranjagam: 
Which colours the blood 
 It increases the quality of blood 
 It lives in intestine and gives red colour to the essence which seperate  from 
the food we take 
 
Saadhagam 
      Which controls the whole body. It has the Accomplishing property.  It lies in heart 
and accomplish the work, via knowledge, mind and desire. 
 
Aalosagam 
 Which brightens the eyes 
 It shows the things to eyes 
 It lies in eyes and shows the shape of all things 
 
Prasagam: 
 Which give  complexion to the skin. 
 It brightens the skin 
 It lies in skin and brightens the skin. 
 
Classificatin of Pitha diseases 
     According to Yugi Vaidhya Chinthamani Pitha  diseases are classified into  42 
types . According to this classification  the symptoms of URATHA PITHAM gives us 
a picture more or less similar to Hypertension. 
 
Classification 
 
ehl;bNdd; gpj;jj;jpd; ngaiuj;jhDk; 
ehw;gj;jpuz;lhd FzhFzq;fs; 
Ml;bNddTU gpj;je;jd;NdhL 
Mkygpj;j kjNdhLd;khj gpj;je; 
jhl;bNdd; jke;j gpj;jk; thj gpjje; 
jdpj;Njhh; gd;dpgpj;jQ; rpNyl;k gpj;je; 
J}l;bNdd;d RNuhzpj gpjje; tpfhu gpj;je; 
Jbahd tpuz gpj;je; njhifiaf; NfNs 
njhifahd Tuj;jgpj;j kpuj;j gpj;jQ; 
Ropfhrg; gpj;jnkhO Rthrg; gpjjk; 
tifahd rp Nyl;k gpj;jq; fUk;gpj;je;jhd; 
khfug;ghd; gpj;jj;Njhl rPuz gpj;jk; 
mifahd tUrpgpj;j nkhpgpj;je;jhd; 
moy;tpj;je; Jbg;gpj;jk; tp\g;gpj;je;jhd; 
Kifahd mjprhug; gpj;je;jhDk; 
%yg;gpj;j Kjph;tpj;j KiwikahNk 
Kiwikahq; fz;l gpj;jNkhL gpj;jk; 
%Lgpj;j eLf;Fg; gpj;jq; fghygpj;jk; 
jpwikahQ; rh;j;jp gpj;je;jhfg; gpj;je; 
jUf;fhd tpf;fy; gpj;jk;  \agpj;je;jhd; 
jpwikahe; jpkph;gpj;jk; typgpj;jNkhL 
rPjgpj;jq; fpUkpgpj;jk rhj;a gpj;jk; 
kwikahk; khh;f;f gpj;jkUj;jPL gpj;jk; 
tifaJ ehw;gj;jpuz;L kfpo;e;J ghNu. 
                                                                              -  Yugi Vaidhya Cinthamani44 
 
According to this verse Pitha diseases are classified into  42 types 
1. Aavuru pitham 
2. Amalaga pitham 
3. Unmadha pitham 
4. Tghamandha pitham 
5. Vatha pitham 
6. Vanni pitham 
7. Silathma pitham 
8. Suronitha pitham 
9. Vigara pitham 
10. Virana pitham 
11. Uraththa pitham 
12. Raththa pitham 
13. Kaasa pitham 
14. Swasa pitham 
15. Semipitham 
16. Karum pitham 
17. Karappan pitham 
18. Aseerana pitham 
19. Aroosi pitham 
20. Eri pitham 
21. Azhal pitham 
22. Thudi pitham 
23. Athisaara pitham 
24. Moola pitham 
25. Vida pitham 
26. Muthir pitham 
27. Kanda pitham 
28. Oodu pitham 
29. Moodu pitham 
30. Naaduku pitham 
31. Kabaala pitham 
32. Sarthi pitham 
33. Thaga pitham 
34. Vikkal pitham 
35. Shaya pitham  (Kaya pitham) 
36. Thimir pitham 
37. Vali pitham 
38. Seetha pitham 
39. Kirumi pihtam 
40. Asathiya pitham 
41. Markkap pitham 
42. Marumdeedu pitham 
 
 
 
 
 
 
 
 
Thingal or nilam 
According to pathartha guna chinthamani 
Thinai or Nilam is classified into five types 
They are 
1. Kurinji  - Mountain and its surroundings 
2. Mullai - Forest and its surroundings 
3. Marutham -  Field and its surroundings 
4. Neithal  -  Sea and its surroundings 
5. Paalai -  Desert and its surroundings 
 
 
 
1. Kurinji 
FwpQ;rp tU epyj;jpw; nfhw;wKz;b uj;jk; 
cwpq;rp tU RuK Kz;lhk; -  mwpQiuf; 
ifaNk jq;Fj uj;jhik ty;iy Aq;fjpf;Fk; 
IaNk jq;F kwp 
 
According to this verse in kurinji kabha diseases, fever which cause anaemia tumour 
in stomach (Aamai katti)  are common 
 
2.  Mullai 
Ky;iy epyj;jika Ke;epiu NktpDkt; 
nty;iy epiyj;j gpj;j nka;Jwq;fhz; - my;yntdpd; 
thjnkhop ahjjDz; kd;D kit topNeha;g; 
Ngjnkhop ahjiwag; gpd;G 
 
According to this verse in Mullai Pitha diseases, liver diseases and Vatha diseases 
commonly occur 
 
3. Marutham 
kUjepy ed;dPh; tsnkhd;iwf ;nfhz;Nl 
nghU jepy khjpaNeha; Nghf;Fq;  - fUjepyj; 
jhwpljQ; R+o tUe;Jtnud; whw; gpzpnay; 
VwpujQ; R+o;tpf;F kpy; 
 
According to this verse in Marutham Vatha, Pitham and Kabha diseases all get cured.  
It is the best place to live. 
 
4.Neithal 
nea;jdpy NkYth;g;ig ePq;fh JwpDkJ 
nta;jdpy Nkjq;F tPlhFk; -  neha;jPd; 
kUq;F liy Kf;fhf;fp ty;YWg;ig tPf;Fq; 
fU q;Fliyf; fPopwf;Fq; fhz; 
 
According  to  this  verse  in  Neithal pitha vayu, filariasis and  Hernia  occur  
commonly 
5. Paalai 
ghiy epyk;Nghw; gliug; gpwg;gpf;f 
Niyepy kPahJ tphpj;jw;F -  Ntiyepy 
Kg;gpzpf;F kpy;yhk; KiwNa atw;wyhk; 
vg;gpzpf;F  kpy;yh kf;njd; 
 According to this verse in Paalai Vatham, Pithtam and Kabham get deranged and lead 
to various diseases. 
 
FwpQ;rp epyNk thjkhq; fhZk; ghiy gpj;jkhQ; 
nrwpe;j kUjQ; rpNyj;kkhq; rpNyj;kthj Ky;iyajhk; 
epiwe;j nea;jy; thjgpj;jk; epiyq;fsjid kaf;fh 
Yiwe;j tpahjp fye;jpUf;F Kghakwpe;J nra;tPNu 
                                - PadhinenSiddharnaadisaaam48 
 
                                                                        
According to this verse the diseases that develop in each land in as follows 
Kuringi – Vatha diseases 
Mullai -  Kabha vatha diseases 
Marutham -  Kabha diseases 
Neithal  -  Vatha pitha disease 
Palali  -  Pitha diseases 
 
 
 
 
 
 
 
Paruva Kaalangal 
A year is classified into six seasons eachy consitutes two months , they are 
 
 
 
 
 
 
 
 
 
 
VANMAI: 
1.Iyrarkai vanmai 
It is formed naturally from Mukkuna . These are Sathuva, Rajotha and thamo gunaas 
 
2. Kaala vanmai 
It is due to  year  (Age)  and the Paruva kalangal 
3. Seyarkai vanmai 
It secure the body which is formed through the Mukkuna by proper day to day diet 
according to that  ‘Gunam’  and by drug intake without disturbing the vitality  of the 
body 
 
Season  Months 
   
Kaarkaalam  Aavani and 
Purattasi 
   
Koodhir kaalam  Iyppasi and 
Kaarththigai 
   
Munpani Kaalam  Maargazhi and thai 
   
Pin pani kaalam  Maasi and panguni 
   
Elavenir Kaalam  
 
Chiththirai and 
Vaigaasi 
Muthu venir kaalam  Aani and Aadi 
Mukkutrangal 
    Normal proportions and functions are important to maintain a normal healthy body.  
If changes take place in Mukkutram it may lead to diseases. So the changes in 
Mukkutram is the main source in diagnostic purpose of diseases. 
 
URATHA PITHAM 
Definition:- 
     Urathapitham is the one having similar symptoms with Hypertension among the 42 
types mentioned in Yugivaithyachinthamani. The symptoms are Giddiness, Head 
ache, Fatigue. 
cuj;jgpj;jk; 
 
           “%Hf;fkhq; NfhgkJkpfTz; lhL 
Kidahftbfbf;Fr; rz;ilnfhs;Sk; 
      MHf;fkhaf; $tpNatpiur;ryhF 
           khjhd ghjhsk; Ngjp ahFk; 
                 ehHf;fkha; ed;ikJd;ikNjhd;whkw;whd; 
          eyf;fkhffz; rptf;Fe; J}f;fkpy;iy 
                 CHf;fkhAlo;J} ypf;FKg;G 
       Kuj;jtpj;jthjj;jpYz;ikjhNd” 
                                                                                        -  Yugi Vaidhya Cinthamani31 
 
 
 Frequent angerness. 
 Aggressive  behaviour 
 Speaking in high – pitched voice 
 Frequent diarrhoea. 
 Inability to differentiate good things 
 Redness of the eyes. 
 Insomnia 
 Obesity. 
 DIFFERENTIAL DIAGNOSIS:- 
rPj gpj;jk; 
 
td;ikahAlk;ngq;Fk; tbAe; jz;zPH 
  kaf;fkhAly;fdj;Jg; ghukhFk; 
Gz;ikaha;g; gplhpjdp>KUTz; lhFk; 
  nghUkpNatapWg; gpre;jhdhFk; 
jpz;ikahAly;fdj;Jr; nrhf;FNghyhQ; 
  rPwpNakpftUkpr; rpe;ijNflhQ; 
nrz;ikaha; tha;ePHjhd; cg;Giwf;FQ; 
  rpWePUQ; rpfg;ghFe; rPjgpj;jk;. 
                                                                        -YugiVaidhyaCinthamani34 
The clinical feature of seetha pitham are: 
 Excess sweating 
 Giddiness 
 Pain in the neck 
 Abdominal distension 
 Tiredness 
 Cough 
 Redness of urine. 
 
     Even though, the symptoms of seetha pitham  are related to urathapitham, cough,   
redness of urine, pain in the neck are not present in urathapitham, so it is varied from 
‘Urathapitham’. 
 
thj gpj;jk; 
 
jhpg;ghdfz;jidNakpfkiwf;Fe; 
  jhpahjkpftiur;ry; Gifr;rYz;b 
kphpg;ghdfz;kpd; kpdpaha; Rod;W 
  kpf;fePHjJk;gpNafyq;fpepw;Fk; 
 thpg;ghdkpd;Dlk;GtpaHitghF 
  kaf;fnkhljpaf;fkha; the;jpahFk; 
Fwpg;ghdnfhk;NgKk; mdpdk; Ntz;lhq; 
  $wpNdhk; thjgpj;jnfhs;ifjhNd! 
                                                                         -  Yugi Vaidhya Cinthamani35 
Description:- 
 Fatigue 
 Giddiness 
 Excessive sweating 
 Vomitting 
 Loss of appetite 
 Blurring of vision 
      Even though the symptoms of vathapitham are related to Urathapitham vomiting, 
loss of appetite are not present in Urathapitham. So it is varied from Urathapitam. 
      According to Theriyarvagadam, Thalaichuzhalpitham belongs to Pitha disease. 
jiyr;Roy; gpj;jk; 
 
“moy;gpj;jKlk; ngy;yhkiyaha; tPRk; 
mjpfkjha; jhfK kpfTz;lhFk; 
Roy; gpj;jk; elf;ifapNyfpWfpWntd;W 
Rw;wptpKf; fhl;LnkdkUtWf;Fk;” 
                                                                         -Yugi Vaidhya Cinthamani36 
    The above symptoms are offer the complications of Diabetes mellitus, 
So it is varied from Urathapitham. 
Complication  of  Urathapitham According to “Agathiyar Gunavagadam” 
'Nfslh ,Ujaj;jpy; Jbg; Gz;lhFk; 
Nfbahd %r;RKl;ly; Njhd;Wkg;gh 
ePslhNtfkha; elf;fNthl;lh 
eprkhd ,lJgf;f ,uj;jhraj;jpy; 
thslhNtjidAk; czHr;rpFd;wp 
tskhdrpurpdpy;jhd; typAk; fhl;Lk; 
Njslhmbf;fbj;jhd; kaf;fk; cz;lhk; 
Njspthd ,Ujaj;jpy; fhJitj;Jf;NfNs 
fhJitj;Jf; Nfl;lhf;fhy; ,Ujaj;jpd; 
fdkhdrj;jq;fs; Nfl;blhJ 
epjpaha;f; ifiaitj;Jg; ghHjhahdhy; 
epr;rakha;g; gykhfmbf;Fk; ghU 
Nrhjpj;jrpfpr;iriaehd; nrhy;Ntd; ghU 
Rfkhf;ftifawpar; nrhy;Ntd;ghNu” 
                                                                            -  Agathiyar Gunavagadam39 
 
Description:- 
 Palpitation 
 Breathlessness 
 Difficulty in walking 
 Pain in the left sided chest 
 Muffled heart-sounds on auscultation 
 Having opical impulse on palpation 
 Fainting 
 Head ache 
According to Pararasasekaram. 
gpj;jkjpfhpj;jyhy; gpwf;Fk; NtW Neha;fs; 
 
“gpj;jNkajpfhpj;jhw; ngUj;jpLq; frKq; fhrk; 
nkj;jNttPf;feP Njhd;W kpFj;jpL KyHe;J #iy 
xj;jNjhepuj;j Fdpk Nkhba Fly;thjq;fs; 
va;jpLnrq;fz; khhpapd;dKkNdfNeha;fs;” 
                                                                                       -Pararasasekaram30 
Description:- 
 Respiratory disease 
 Oedema 
 Peripheral neuritis 
 Persistent gastric ulcer. 
. 
PINIYARI MURAIMAI (DIAGNOSIS): 
    Diagnosis is the very important thing for a physician by which he deals the disease 
by finding its cause and is helpful to undertake a correct line of treatment and also 
prognosis. 
 
The diagnosis is based on 
 Poriyalarithal (Inspection) 
 Pulanal arithal (Palpation) 
 Vinathal (Interrogation) and 
 Envagai thervugal. 
 
1.Poriyal arithal 
    Porigal are the five organs of perception. They are nose, tongue, eyes, skin & ears. 
Poriyalarithal is examining the pori of the patient by pori of the physician. 
 
2. Pulanal arithal 
    Pulangal are the five object of senses namely smell, taste, sight, sensation and 
sound. 
 
3.Vinathal (Interrogation): 
     By vinathal, the physician knows about the patient’s name, age, occupation, native 
place (thinai), family history, socio economic status, dietary habits, his complaints,  
history of past illness, relevant history of treatment and habits etc., 
 
 
 EZHU UDAL THATHUKKAL 
1. Saaram 
    It strengthens the body and mind .  It is affected in Uratha pitham and causes 
general debility 
2. Senneer 
   It gives power, knowledge, boldness to the mankind and red colour to the  blood.  It 
is affected in Uratha pitham causes anaemia. 
3. Oon 
   It gives the structure, shape to the body and it is  responsible for the movements of 
the body.  It is affected in Uratha pitham causes emaciation. 
4. Kozhuppu 
   It lubricates the joints and control their function 
It is not affected in Uratha pitham 
5.  Enbu 
   It protects the joints and facilitates their function. 
it is affected in Uratha pitham causes pain in the joints 
6.  Moolai 
    It protects the joints and facilitates their function and gives strength  to bone.It is 
not affected in Uratha pitham 
 
7. Sukkilam or Suronitham 
It is concerned with reproduction.  It is not affected in Uratha pitham 
 
4.Envagai thervugal: 
    It is the basis diagnostic principle and the unique speciality of the Siddha system of 
medicine. The following verse’s reveals this follows. 
 
Envagai thervugal are 
 Naadi (pulse) 
 Sparisam (palpation) 
 Naa (tongue) 
 Niram (colour of the skin) 
 Mozhi (speech) 
 Vizhi (eyes) 
 Malam (motion) 
 Moothiram (urine) 
 
    Envagai thervugal gives a definite idea to diagnose Uratha pitham. This is 
explained as follows. 
    Three vital forces namely vatham, pitham and kabam. The three uyirthathukkal 
which organise, regularise and integrate the life activities in each and every living 
being. 
    The same three fundamentals are described as Edakalai, pinkala and suzhumunai in 
yoga tents which describes the methods for preventing disease and for prolonging life 
to altairwiselom and salvation. The same explanation is also in Siddha tents for under 
standing the unity in diversity to active health, weath and happiness and satisfaction 
    On the basis of the examination of the senses and on the basis of eight special 
examination and interrogation all the details of the disease factor are collected and 
their final diagnoses is confirmed with those findings made on Naadiparichai. 
 
 
1.Naadi 
In the Noi Nadal Noi Mudhal Nadal text it is defined as follows, 
ehb 
 
“capHf;fhjhuk; KapHj; jhnjdTk; 
Kg;gphpthfpKf;Fz kDfp 
cliyA KapiuA Nkhk;gpf; fhj;J 
tUkd KJkiw tFf;Fe; JzpNt” 
                                                                              -Noi naadal noi muthal naadal38 
 
          Naadi is omnipresent cosmic vibrant force connecting the malroscespnic with 
the human body is a subtte diagnostic tool handed by the Siddhars. These vibrations 
enter into the human body from the universe, keep the life vibrator continuously and 
generate the energy required for the human metabolism. Naadi is the vital force. The 
examination of Naadi has been recognised as one of the principal means of diagnosis 
and prognosis of the disease from time immemorial. Any change in the Mukkutram is 
best diagnosed by feeling the Naadi. The power of Naadi manifests in the body as 
 
Genesis of naadi: 
       The three Thathukkal are formed by the combination of three Naadies with three 
Vayus. 
Idakalai + Abanan = Vatham 
Pinkalai + Piranan = Pitham 
Suzhumunai + Samanan = Kabam 
      These can be felt one inch above the wrist on the radial side by means of palpation 
with the tips of index, middle and ring finger corresponding to vatham, pitham and 
kabam respectively. 
 
2.Sparisam (palpation): 
     By sparisam, the temperature of sin (heat or cold), smoothness, sweat, dryness, 
hard patches, swelling, abnormal growth, tenderness, ulcers, enlargements, 
nourishment can be noted. 
 
3.Naa (Tongue): 
     In the examination of tongue, its colour, coating, dryness, deviationandmovement, 
variations in taste and the conditions of teeth and gums can be noted. 
 
4.Niram (colour): 
    By examining the niram, the type of udal (body) whether vatham (black), pitham 
(red or yellow) and kabam (white) or mixed, cyanosis and pallor of the body can be 
noted. 
 
5.Mozhi (speech or voice): 
    In the examination of mozhi, high or low pitched voice, slurring and incoherent 
speech, nasal or crying, hoarseness of voice can be noted. 
 
6.Vizhi (Eye): 
    In the examination of vizhi, the change in the colour of the eye such as redness, 
yellowishness, pallor etc may be noted. With these dryness, lacrimation, sharpness of 
vision, response of the pupile, falling of hair in eye-lashes, inflammations and 
ulcerations may also be noted. 
 
 
 
7.Malam (stools): 
    In the examination of malam, its nature (whether it is solid, semisolid or liquid), its 
colour, its quantity (increased or decreased) can be noted. Other examinations like 
diarrhoea, presence of blood, mucus, undigested matter in the stools and odour should 
be studied. 
8.Moothiram(urine): 
    In the examination of urine, the colour, odour, quantity of urine, the presence of 
froath, deposits, blood, pus, small stones, abnormal constituents such as sugar, 
proteins etc., and the frequency of urination can be noted. 
Neerkuri and Neikuri are the two methods used to diagnose the disease. They are 
discussed below. 
Neerkuri: 
   According to this verse, the general features of urine, ie., niram, edai, manam, nurai 
and enjal are analysed. 
 Niram indicates the colour of the urine voided. 
 Edai indicates the specific gravity of the urine voided 
 Manam indicates the smell of the urine voided. 
 Nurai indicates the froathy nature of the urine voided. 
 Enjal indicates the quantity (increased or decreased) of the urine voided. 
 
Neikuri: 
     For this examination, urine is collected in the early morning in a pure glass vessel. 
The patient should be prepared specially for this before a day in a manner of not 
taking excessive diet in irregular timing etc. 
    A drop of gingelly oil is dropped on a wide vessel containing the urine to be tested 
and  placed in the sunlight in a calm place. The derangement of the three thathuvas 
and  the disease can be diagnosed by the behaviour of gingelly oil on the surface of 
the urine. 
PATHOLOGY 
      In Siddha system of medicine, disease have been classified in the basis of 
Mukkuttam.  Uratha Pitham Noi is one among the Pitha dominant disease.  In this  
disease the Azhal Kuttram is elevated from its normal plane.  According to Noi Nadal 
Noi Muthal Nadal Thirattu the patho physiology of Uratha Pitham Noi is explained as 
elevation of Pitha from its normal unit and thereby increase the heat of the body.             
Then the normal function of Dhasavayu have been affected.  “Due to increased Azhal 
and the elevated function of Vayu the disease arise”.  Though the prime causative 
factor is Azhal kuttram, the other two humours Vatha and Kaba are also affected 
simultaneously.  Because of that only the disease is classified in the basis of three 
Dhosas. 
The three thosam theory has a strong hold on the study of Gunam. 
1. Sattuva 
It is the illuminating pure and good quality. 
2. Rajo 
It is the quality of mobility of activity.  It makes a person active and energetic tense 
and willful 
3. Thamo 
     It is the dark and restraining quality. 
    Of these three gunas the Rajo Guna is of pitha type.  A man in whom Rajo Guna 
predominates has inner thrist and affectionate.  As he is passionate and covetous, he 
hurts others.  He is unsteady, fickle, easily distracted as well as ambition and 
acuisitive,  He shrinks from unpleasant things and clings to pleasant ones.  His speech 
is sour and his stomach greedy.  These are the normal  qualities are Rajo Guna 
individuals.  All the human beings are affected by these Guna factor.  Unless the bad 
qualities of Gunas are controlled disease like Uratha Pitham Noi will occur due to 
humoral changes in the body as a stress factor. 
 
 Line   of  treatment  Siddha   literatures. 
         Among  these  remedies, 
                 Puthina theeneer-15 to 30ml twice a day with water,after food 
3. Diet: 
         Siddhars advice the diet regimen for pitha patients and they are explained below: 
Diet to be add 
 1.Kanchi(Rice water). 
2.Athi pinchu(Ficus glomavata) 
3.Avarai pinchu(Dolichos lab-lab) 
4.Kathari pinchu (Solanum rubrum) 
5.Ponnanganni keerai(Alternanthera sessilis) 
6.Siru keerai (Amaranthus gangeticus) 
7.Arai keerai(Portulaca quadrifolia) 
8.Puliyarai keerai (Oxalis korniculatus). 
9.Chukkan keerai (Rumex vesicarius). 
 
Diet  restriction: 
    Siddhars advice to avoid sour, salty and  pungent food for Uratha Pitham noi.  
Nowadays all the Patient were advised to take low sodium diet (less than 5mg per 
day) and to take low fatty diet (especially oils containing mono-unsaturated fatty acids 
(MUFA). 
Yoga  therapy: 
    Yogasanam is one of the part of Astanga Yogam.  It controls mind and body by 
various mechanisms.  So it has been applied to control various stress-related diseases 
nowadays as an  adjuvant therapy. 
 
 
Mechanisam: 
    Every Asanas require the spine to be kept erect and to keep riched blood supply to 
the pelvic region.  This stimulates kundalini, which controls the mind and body. 
   In modern study, it seems to stimulation of Psycho-neuro hormonal axis which 
controls the sympathetic overactivity.  This in turn eliminates free radicals, 
catecholamines and secrets endorphins and encephalins which is a natural steroidal 
hormone which helps to maintain the body and mind active and releive the stress. 
Asanas  beneficial  in  Hypertension: 
 Padmasanam 
 Pranayamam 
 Savasanam. 
 Surya namaskaram 
 
Relaxation   Therapy: 
     It  is  particularly  useful  for  anxiety disorders,  Psychosomatic  disorders (e.g 
Hypertension) and  in other conditions  where  anxiety  is  associated (e.g. smoking, 
sexual disturbances, sleeplessness).  It  is  usually done  in  a  calm  room with a  
relaxed  mind  in the  lying  down  posture  with palms  facing  upwards  for  about  
15 to 20 minutes  twice daily.  The   underlying   principle   is  the  counterproductive  
nature  of  relaxation  towards anxiety.  So   the cycle (anxiety leading to muscle 
tension which in turn aggravates anxiety) is broken  by  this  approach. 
    In  this method, relaxation  is  done  through  concentration  on  certain  thoughts by 
Autogenous training.  In the commonly used Jacobson’s method, the client is taught 
to relax one  group of muscles  at  a  particular time (by alternate contraction and 
relaxation) which progresses  slowly  from  head  to  foot  until  the  whole  body  is  
relaxed. 
    The   person   also   knows  the  adverse  effect   of  muscle  contraction.  For  
example,  the  relaxation  of  head  muscles   will  often  correct tension  Headache.  
So  it  is a   simple  and  highly  useful technique. 
 
Transcendental   Meditation: 
     It is an unusual state of consciousness taking qualities of both sleep and 
wakefulness with a profound state of rest.  It decreases the oxygen consumption, heart 
rate respiratory rate and sympathetic overactivity.  So it reduces tension and anxiety.  
It improves interpersonal relationships and concentration power. 
There are number of meditative processes like attending to a mental repetation of a 
sound or mantra etc. 
 
In our programme, the patient was asked to repeat a word (as he likes) silently for 
about 20 minutes twice daily in a relaxed, calm, comfortable position with eyes 
closed,  It removes the inner conflicts, anxiety and mental stress very effectively.  So 
a sense of well-being and mental relaxation with good sleep was observed in  Patients 
who do this mediation regularly. 
 
Prevention: 
1. Relieving   the  tension  or  the  stress  and  stain  of  life  by  reducing  
unnecessary   burden  and  responsibilities. 
2. Transforming   the  attitudes  and  belief  systems  so as  to  reduce  anxiety  
and excitement. 
3. Good   sleep. 
4. Low   sodium   chloride   intake (less than 5gm per day). 
5. Totally   avoiding   intake   of   tabacco. 
6. Stopping   alcohol   consumption   or   reducing  it  considerable. 
7. Overcoming   obesity. 
8. Avoiding   constipation. 
9. Light   regular   exercise (avoid undue physical strain and exertion). 
10. Practice   of  relaxation  and  positive  thinking. 
 
 
 
 
  
 
 
 
 
 
 
 
 
MODERN ASPECT 
 
 
 
MODERN ASPECTS 
HYPERTENSION 
DEFINITION: 
      The Hypertension is used to describe an increase in blood pressure, systemic 
hypertension is an increase in the pressure in the arteries of the systemic circulation. 
PH is an increase in the pressure in the pulmonary arteries. Portal hypertension is an 
increase in the pressure in the portal veins. When the term hypertension is used alone, 
it means systemic hypertension. 
SYSTEMIC  HYPERTENSION: 
     Systemic Hypertension cannot be define precisely. The normal arterial blood 
pressure is not the same in all people, and even in a single individual it varies widly 
under conditions of physical or emotional stress. 
BP scheme for adults (in mmHg) 
• Normal systolic Bp (SBP) < 120 and diastolic Bp (DBp) <80 
• Prehypertensive: SBp 120 – 139 or DBp 80 – 89. 
• Stage 1 hypertension : SBp 140 – 159 or DBp 90 – 99. 
• Stage 2 hypertension : SBp <160 or DBp >= 100. 
Hypertension becomes more common as age increases. 
    For patients with hypertensions, the basic Bp control target is <140/ <90 mmHg, 
but the target is <130/<80mm Hg, for patients with diabetes or renal disease. A 
sustained diastolic pressure >89mm Hg and systolic pressure in excess of 139mm Hg 
are associated with a measurably increased risk of atherosclerosis. 
ANATOMY OF THE HEART 
     The heart is a muscular organ in humans and other animals, which pumps blood 
through the blood vessels of the circulatory system. Blood provides the body with 
oxygen and nutrients, as well as assists in the removal of metabolic wastes. In 
humans, the heart is located between the lungs, in the middle compartment of the 
chest. 
In humans, other mammals, and birds, the heart is divided into four chambers: upper 
left and right atria; and lower left and right ventricles. Commonly the right atrium and 
ventricle are referred together as the right heart and their left counterparts as the left 
heart. Fish, in contrast, have two chambers, an atrium and a ventricle, while reptiles 
have three chambers. In a healthy heart blood flows one way through the heart due to 
heart valves, which prevent backflow.The heart is enclosed in a protective sac, the 
pericardium, which also contains a small amount of fluid. The wall of the heart is 
made up of three layers: epicardium, myocardium, and endocardium. 
     The heart pumps blood with a rhythm determined by a group of pacemaking cells 
in the sinoatrial node. These generate a current that causes contraction of the heart, 
traveling through the atrioventricular node and along the conduction system of the 
heart. The heart receives blood low in oxygen from the systemic circulation, which 
enters the right atrium from the superior and inferior venae cavae and passes to the 
right ventricle. From here it is pumped into the pulmonary circulation, through the 
lungs where it receives oxygen and gives off carbon dioxide. Oxygenated blood then 
returns to the left atrium, passes through the left ventricle and is pumped out through 
the aorta to the systemic circulation−where the oxygen is used and metabolized to 
carbon dioxide. The heart beats at a resting rate close to 72 beats per minute. Exercise 
temporarily increases the rate, but lowers resting heart rate in the long term, and is 
good for heart health. 
    Cardiovascular diseases (CVD) are the most common cause of death globally as of 
2008, accounting for 30% of deaths. Of these more than three quarters are a result of 
coronary artery disease and stroke. Risk factors include: smoking, being overweight, 
little exercise, high cholesterol, high blood pressure, and poorly controlled diabetes, 
among others.Cardiovascular diseases frequently have no symptoms or may cause 
chest pain or shortness of breath. Diagnosis of heart disease is often done by the 
taking of a medical history, listening to the heart-sounds with a stethoscope, ECG, and 
ultrasound. Specialists who focus on diseases of the heart are called cardiologists, 
although many specialties of medicine may be involved in treatment. 
 
 
Chambers 
      The heart has four chambers, two upper atria, the receiving chambers, and two 
lower ventricles, the discharging chambers. The atria open into the ventricles via the 
atrioventricular valves, present in the atrioventricular septum. This distinction is 
visible also on the surface of the heart as the coronary sulcus. There is an ear-shaped 
structure in the upper right atrium called the right atrial appendage, or auricle, and 
another in the upper left atrium, the left atrial appendage.The right atrium and the 
right ventricle together are sometimes referred to as the right heart. Similarly, the left 
atrium and the left ventricle together are sometimes referred to as the left heart. The 
ventricles are separated from each other by the interventricular septum, visible on the 
surface of the heart as the anterior longitudinal sulcus and the posterior 
interventricular sulcus. 
    The cardiac skeleton is made of dense connective tissue and this gives structure to 
the heart. It forms the atrioventricular septum which separates the atria from the 
ventricles, and the fibrous rings which serve as bases for the four heart valves. The 
cardiac skeleton also provides an important boundary in the heart's electrical 
conduction system since collagen cannot conduct electricity. The interatrial septum 
separates the atria and the interventricular septum separates the ventricles. The 
interventricular septum is much thicker than the interatrial septum, since the ventricles 
need to generate greater pressure when they contract. 
Valves 
 
With the atria and major vessels removed, all four valves are clearly visible 
     The heart has four valves, which separate its chambers. One valve lies between 
each atrium and ventricle, and one valve rests at the exit of each ventricle. 
   The valves between the atria and ventricles are called the atrioventricular valves. 
Between the right atrium and the right ventricle is the tricuspid valve. The tricuspid 
valve has three cusps, which connect to chordae tendinae and three papillary muscles 
named the anterior, posterior, and septal muscles, after their relative positions. The 
mitral valve lies between the left atrium and left ventricle. It is also known as the 
bicuspid valve due to its having two cusps, an anterior and a posterior cusp. These 
cusps are also attached via chordae tendinae to two papillary muscles projecting from 
the ventricular wall. 
   The papillary muscles extend from the walls of the heart to valves by cartilaginous 
connections called chordae tendinae. These muscles prevent the valves from falling 
too far back when they close. During the relaxation phase of the cardiac cycle, the 
papillary muscles are also relaxed and the tension on the chordae tendineae is slight. 
As the heart chambers contract, so do the papillary muscles. This creates tension on 
the chordae tendineae, helping to hold the cusps of the atrioventricular valves in place 
and preventing them from being blown back into the atria. 
   Two additional semilunar valves sit at the exit of each of the ventricles. The 
pulmonary valve is located at the base of the pulmonary artery. This has three cusps 
which are not attached to any papillary muscles. When the ventricle relaxes blood 
flows back into the ventricle from the artery and this flow of blood fills the pocket-
like valve, pressing against the cusps which close to seal the valve. The semilunar 
aortic valve is at the base of the aorta and also is not attached to papillary muscles. 
This too has three cusps which close with the pressure of the blood flowing back from 
the aorta. 
Right heart 
   The right heart consists of two chambers, the right atrium and the right ventricle, 
separated by a valve, the tricuspid valve. 
   The right atrium receives blood almost continuously from the body's two major 
veins, the superior and inferior venae cavae. A small amount of blood from the 
coronary circulation also drains into the right atrium via the coronary sinus, which is 
immediately above and to the middle of the opening of the inferior vena cava. In the 
wall of the right atrium is an oval-shaped depression known as the fossa ovalis, which 
is a remnant of an opening in the fetal heart known as the foramen ovale.Most of the 
internal surface of the right atrium is smooth, the depression of the fossa ovalis is 
medial, and the anterior surface has prominent ridges of pectinate muscles, which are 
also present in the right atrial appendage. 
    The right atrium is connected to the right ventricle by the tricuspid valve. The walls 
of the right ventricle are lined with trabeculae carneae, ridges of cardiac muscle 
covered by endocardium. In addition to these muscular ridges, a band of cardiac 
muscle, also covered by endocardium, known as the moderator band reinforces the 
thin walls of the right ventricle and plays a crucial role in cardiac conduction. It arises 
from the lower part of the interventricular septum and crosses the interior space of the 
right ventricle to connect with the inferior papillary muscle. The right ventricle tapers 
into the pulmonary trunk, into which it ejects blood when contracting. The pulmonary 
trunk branches into the left and right pulmonary arteries that carry the blood to each 
lung. The pulmonary valve lies between the right heart and the pulmonary trunk. 
Left heart 
     The left heart has two chambers: the left atrium, and the left ventricle, separated by 
the mitral valve. 
     The left atrium receives oxygenated blood back from the lungs via one of the four 
pulmonary veins. The left atrium has an outpouching called the left atrial appendage. 
Like the right atrium, the left atrium is lined by pectinate muscles. The left atrium is 
connected to the left ventricle by the mitral valve. 
    The left ventricle is much thicker as compared with the right, due to the greater 
force needed to pump blood to the entire body. Like the right ventricle, the left also 
has trabeculae carneae, but there is no moderator band. The left ventricle pumps blood 
to the body through the aortic valve and into the aorta. Two small openings above the 
aortic valve carry blood to the heart itself, the left main coronary artery and the right 
coronary artery. 
 
Heart wall 
 
Layers of the heart wall, including visceral and parietal pericardium. 
    The heart wall is made up of three layers: the inner endocardium, middle 
myocardium and outer epicardium. These are surrounded by a double-membraned sac 
called the pericardium. 
    The innermost layer of the heart is called the endocardium. It is made up of a lining 
of simple squamous epithelium, and covers heart chambers and valves. It is 
continuous with the endothelium of the veins and arteries of the heart, and is joined to 
the myocardium with a thin layer of connective tissue. The endocardium, by secreting 
endothelins, may also play a role in regulating the contraction of the myocardium. 
 The swirling pattern of myocardium helps the heart pump effectively 
    The middle layer of the heart wall is the myocardium, which is the cardiac muscle – 
a layer of involuntary striated muscle tissue surrounded by a framework of collagen. 
The cardiac muscle pattern is elegant and complex, as the muscle cells swirl and spiral 
around the chambers of the heart, with the outer muscles forming a figure 8 pattern 
around the atria and around the bases of the great vessels, and inner muscles 
formining a figure 8 around the two ventricles and proceed toward the apex. This 
complex swirling pattern allows the heart to pump blood more effectively. 
    There are two types of cells in cardiac muscle: muscle cells which have the ability 
to contract easily, and pacemaker cells of the conducting system. The muscle cells 
make up the bulk (99%) of cells in the atria and ventricles.              These contractile 
cells are connected by intercalated discs which allow a rapid response to impulses of 
action potential from the pacemaker cells. The intercalated discs allow the cells to act 
as a syncytium and enable the contractions that pump blood through the heart and into 
the major arteries. The pacemaker cells make up 1% of cells and form the conduction 
system of the heart. They are generally much smaller than the contractile cells and 
have few myofibrils which gives them limited contractibility. Their function is similar 
in many respects to neurons. Cardiac muscle tissue has autorhythmicity, the unique 
ability to initiate a cardiac action potential at a fixed rate – spreading the impulse 
rapidly from cell to cell to trigger the contraction of the entire heart. 
    The pericardium surrounds the heart. It consists of two membranes: an inner serous 
membrane called the epicardium, and an outer fibrous membrane. Blood vessels and 
nerves reach the cardiac muscle from the epicardium. These help influence the heart 
rate. These enclose the pericardial cavity which contains the pericardial fluid that 
lubricates the surface of the heart. 
Nerve supply 
 
Autonomic innervation of the heart 
     The heart receives nerve signals from the vagus nerve and from nerves arising 
from the sympathetic trunk. These nerves act to influence, but not control, the heart 
rate. Sympathetic nerves also influence the force of heart contraction. Signals that 
travel along these nerves arise from two paired cardiovascular centres in the medulla 
oblongata. The vagus nerve of the parasympathetic nervous system acts to decrease 
the heart rate, and nerves from the sympathetic trunk act to increase the heart rate. 
These nerves form a network of nerves that lies over the heart called the cardiac 
plexus. 
 
 
 
Hypertension 
 
Definition 
      Hypertension is high blood pressure. Blood pressure is the force of blood pushing 
against the walls of arteries as it flows through them. Arteries are the blood vessels 
that carry oxygenated blood from the heart to the body's tissues. 
Description 
      As blood flows through arteries it pushes against the inside of the artery walls. 
The more pressure the blood exerts on the artery walls, the higher the blood pressure 
will be. The size of small arteries also affects the blood pressure. When the muscular 
walls of arteries are relaxed, or dilated, the pressure of the blood flowing through 
them is lower than when the artery walls narrow, or constrict. 
    Blood pressure is highest when the heart beats to push blood out into the arteries. 
When the heart relaxes to fill with blood again, the pressure is at its lowest point. 
Blood pressure when the heart beats is called systolic pressure. Blood pressure when 
the heart is at rest is called diastolic pressure. When blood pressure is measured, the 
systolic pressure is stated first and the diastolic pressure second. Blood pressure is 
measured in millimeters of mercury (mm Hg). For example, if a person's systolic 
pressure is 120 and diastolic pressure is 80, it is written as 120/80 mm Hg. The 
American Heart Association has long considred blood pressure less than 140 over 90 
normal for adults. However, the National Heart, Lung, and Blood Institute in 
Bethesda, Maryland released new clinical guidelines for blood pressure in 2003, 
lowering the standard normal readings. A normal reading was lowered to less than 
120 over less than 80. 
    Hypertension is a major health problem, especially because it has no symptoms. 
Many people have hypertension without knowing it. In the United States, about 50 
million people age six and older have high blood pressure. Hypertension is more 
common in men than women and in people over the age of 65 than in younger 
persons. More than half of all Americans over the age of 65 have hypertension. It also 
is more common in African-Americans than in white Americans. 
   Hypertension is serious because people with the condition have a higher risk for 
heart disease and other medical problems than people with normal blood pressure. 
Serious complications can be avoided by getting regular blood pressure checks and 
treating hypertension as soon as it is diagnosed. 
If left untreated, hypertension can lead to the following medical conditions: 
• Arteriosclerosis, also called atherosclerosis 
• Heart attack 
• Stroke 
• Enlarged heart 
• Kidney damage. 
    Arteriosclerosis is hardening of the arteries. The walls of arteries have a layer of 
muscle and elastic tissue that makes them flexible and able to dilate and constrict as 
blood flows through them. High blood pressure can make the artery walls thicken and 
harden. 
   Arteries narrowed by arteriosclerosis may not deliver enough blood to organs and 
other tissues. Reduced or blocked blood flow to the heart can cause a heart attack. If 
an artery to the brain is blocked, a stroke can result. 
Hypertension makes the heart work harder to pump blood through the body. The extra 
workload can make the heart muscle thicken and stretch. When the heart becomes too 
enlarged it cannot pump enough blood. If the hypertension is not treated, the heart 
may fail. 
   The kidneys remove the body's wastes from the blood. If hypertension thickens the 
arteries to the kidneys, less waste can be filtered from the blood. As the condition 
worsens, the kidneys fail and wastes build up in the blood. Dialysis or a kidney 
transplant are needed when the kidneys fail. About 25% of people who receive kidney 
dialysis have kidney failure caused by hypertension 
Causes and symptoms 
    Many different actions or situations can normally raise blood pressure. Physical 
activity can temporarily raise blood pressure. Stressful situations can make blood 
pressure go up. When the stress goes away, blood pressure usually returns to normal. 
These temporary increases in blood pressure are not considered hypertension. A 
diagnosis of hypertension is made only when a person has multiple high blood 
pressure readings over a period of time. 
   The cause of hypertension is not known in 90 to 95 percent of the people who have 
it. Hypertension without a known cause is called primary or essential hypertension. 
    When a person has hypertension caused by another medical condition, it is called 
secondary hypertension. Secondary hypertension can be caused by a number of 
different illnesses. Many people with kidney disorders have secondary hypertension. 
The kidneys regulate the balance of salt and water in the body. If the kidneys cannot 
rid the body of excess salt and water, blood pressure goes up. Kidney infections, a 
narrowing of the arteries that carry blood to the kidneys, called renal artery stenosis, 
and other kidney disorders can disturb the salt and water balance. 
   Cushing's syndrome and tumors of the pituitary and adrenal glands often increase 
levels of the adrenal gland hormones cortisol, adrenalin, and aldosterone, which can 
cause hypertension. Other conditions that can cause hypertension are blood vessel 
diseases, thyroid gland disorders, some prescribed drugs, alcoholism, and pregnancy. 
    Even  though  the  cause of  most  hypertension is  not  known, some  people  have 
risk  factors  that  give  them a greater chance of  getting  hypertension. Many of these 
risk  factors  can be changed to lower the chance of  developing  hypertension or as 
part  of  a  treatment  program  to  lower  blood  pressure. 
Risk factors for hypertension include: 
 Age over 60 
 Male sex 
 Race 
 Heredity 
 Salt sensitivity 
 Obesity 
 Inactive lifestyle 
 Heavy alcohol consumption 
 Use of oral contraceptives 
     Some  risk factors  for  getting  hypertension can  be  changed, while  others  
cannot. Age, male sex, and race  are  risk  factors  that a  person can't do anything 
about. Some  people  inherit  a  tendency  to  get  hypertension. People  with  family 
members  who  have  hypertension  are  more  likely  to  develop  it than  those  
whose  relatives  are  not  hypertensive. People  with  these  risk  factors  can  avoid or 
eliminate  the  other  risk  factors  to  lower their  chance  of  developing hypertension. 
A  2003 report  found  that  the  rise  in  incidence  of  high  blood  pressure  among 
children  is  most likely  due  to  an  increase  in  the  number  of  overweight  and 
obese  children  and  adolescents. 
Diagnosis 
     Because  hypertension  doesn't  cause  symptoms, it  is  important  to  have  blood 
pressure  checked  regularly. Blood  pressure  is  measured with an instrument called a 
sphygmomanometer. A cloth-covered rubber cuff is wrapped around the upper arm 
and inflated. When the cuff is inflated, an artery in the arm is squeezed to 
momentarily stop the flow of blood. Then, the air is let out of the cuff while a 
stethoscope placed over the artery is used to detect the sound of the blood spurting 
back through the artery. This first sound is the systolic pressure, the pressure when the 
heart beats. The last sound heard as the rest of the air is released is the diastolic 
pressure, the pressure between heart beats. Both sounds are recorded on the mercury 
gauge on the sphygmomanometer. 
    Normal  blood  pressure  is  defined by a range of values. Blood  pressure lower 
than 120/80 mm Hg  is  considered  normal. A  number  of  factors  such as pain, 
stress or anxiety  can  cause a  temporary  increase  in  blood  pressure. For  this  
reason, hypertension  is  not  diagnosed  on  one  high  blood  pressure  reading. If  a  
blood pressure  reading  is  120/80  or  higher  for  the  first  time, the  physician will 
have the  person return  for  another  blood  pressure check. Diagnosis of  
hypertension usually  is  made based  on  two  or  more  readings  after the first visit. 
    Systolic  hypertension of  the  elderly  is  common  and  is  diagnosed  when  the 
diastolic  pressure  is  normal or low, but  the systolic is elevated, e.g.170/70 mm Hg. 
This   condition   usually  co-exists  with  hardening  of  the  arteries (atherosclerosis). 
   Blood pressure measurements  are  classified in stages, according to severity: 
 Normal  blood  pressure: less than less than 120/80 mm Hg 
 pre-hypertension: 120-129/80-89 mm Hg 
 Stage 1 hypertension: 140-159/90-99 mm Hg 
 Stage 2 hypertension: at or greater than 160-179/100-109 mm Hg 
A   typical  physical  examination  to  evaluate  hypertension  includes: 
 Medical  and  family history 
 Physical  examination 
 Chest x ray 
 Electrocardiograph (ECG) 
 Blood  and urine tests. 
     The  medical  and  family  history  help  the  physician  determine  if  the  patient  
has any  conditions  or  disorders  that  might  contribute  to  or  cause  the  
hypertension. A   family  history  of  hypertension  might  suggest a  genetic  
predisposition  for hypertension. 
    The physical exam may include several blood pressure readings at different times 
and in different positions. The physician uses a stethoscope to listen to sounds made 
by the   heart  and  blood  flowing  through  the  arteries. The   pulse, reflexes, and 
height and   weight are  checked  and  recorded. Internal   organs  are  palpated, or  
felt, to determine  if  they  are  enlarged. 
   A  chest  x  ray  can  detect  an  enlarged  heart, other  vascular (heart) 
abnormalities, or  lung  disease. 
  An   electrocardiogram (ECG) measures   the  electrical  activity  of  the  heart.  It  
can detect  if  the  heart  muscle  is  enlarged  and  if  there  is  damage  to  the  heart 
muscle  from  blocked  arteries. 
   Urine  and  blood  tests  may  be  done   to  evaluate  health  and  to  detect  the 
presence   of  disorders  that  might  cause  hypertension. 
 
 
 
Classification of  Hypertension 
 
 
 When Systolic pressure falls below 140 mm Hg indicates normal blood 
pressure 
 
 When the diastolic pressure falls below 90 mm Hg which indicates normal 
blood pressure 
 
Factors maintaining arterial blood pressure: 
     There are some factors necessary for the maintenance of the normal blood pressure 
which is called local factors, mechanical factors or determinants of the blood pressure 
These factors which are divided into the heart: 
 Central factors which are pertaining to the heart 
Cardiac output 
Heart Rate 
               Periphery factors which are pertaining to the blood and blood  vessels : 
 Peripheral resistance. 
 Elasticity of arterial walls 
 Blood volume. 
 Capacity of vascular bed. 
Therefore, cardiac output and peripheral resistance are considered more 
important. Therefore, blood pressure is the product of cardiac output and peripheral 
resistance. 
B.P  =   CO  *   PR 
Thus factor affecting cardiac output will affect systolic blood pressure and 
factors affecting peripheral resistance will affect diastolic  blood pressure. 
 
Cardiac output : 
    Cardiac output  depends upon blood volume, venous return, heart rate and force of 
heart beat.  When cardiac output increases  Blood Pressure increase and when cardiac 
output  decreases Blood Pressure decrease  . As per Frank Starlings law, force of 
contraction of heart is directlyproportional to  initial  length  of  muscle fibers .So 
,when the force  of  contraction is more ,cardiac  output is more and the systolic 
pressure rises 
. 
Heart Rate: 
    Moderate changes in the heart rate do not affect  arterial  blood pressure much. 
However, marked alternation in the heart rate affects blood pressure by altering 
cardiac output. 
 
Peripheral resistance : 
    This is the impartant , which maintains diastolic blood pressure. The diastolic blood 
pressure is directly propotional to peripheral resistance. This is offered  to  the  blood  
flow at the  periphery.The resistances offered at arterioles, which are  calledresistance  
vessels. 
Venous return: 
   Blood  pressure  is directly proportional to Venous return. When 
Venous Pressure  increased blood pressure  is  increase and  Venous 
pressure decreased blood pressures decreased 
 
Elasticity of the arterial walls : 
      Blood pressure is inversely proportional to the elasticity of blood vessels. Due  to  
the elastic property, the blood vessels are distensible and  are  able  to maintain  the 
pressure. When the elastic property is lost, blood pressure is increase or elastic 
property   is  decrease  blood pressure decrease. 
 
Blood volume : 
  Blood volume is directly proportional to blood pressure .If it increase blood  pressure 
is increase otherwise if it decrease blood pressure is decrease. 
 
Regulation of Blood Pressures : 
  The regulation of blood pressure is necessary for the proper blood supply to various 
organs according to the needs. 
The regulation of B.P is controlled by four important mechanisms. 
They are 
1. Nervous mechanism. 
2. Renal mechanism. 
3. Endocrine mechanism. 
4. Capillary fluid shift mechanism. 
Nervous mechanism :(Short -Term Regulation) 
   It rapidly readjust the B.P in a few seconds.  These are useful during 
exercise, emotional states and change  in  posture.  The  desired  effects are 
due to 
a) Pressoreceptor sino aortic mechanism. 
b) Increased sympathetic activity and 
c) Central nervous system ischaemic response. 
 
a. Sino aortic mechanism : 
    This mechanism works through the baroreceptor or  pressorecetor mechanism.  
These receptors are spray-type nerve endings that lie in the walls of the large arteries 
especially in the walls of the internal carotid artery, carotid sinus and  the wall of the 
aortic arch. 
    If these receptors stretches due to rise in pressure, it transmits signals into the 
central nervous system, and “feedback” signals are then sent back through the 
autonomic nervous system to reduce blood pressure normally. 
   Baroreceptors are not stimulated by pressures between 0 and 60mmHg.  But above 
60mm Hg they respond progressively more rapidly and reach a maximum at about 
180 mm Hg. In Chronic hypertension, the baroreceptor reflex mechanism is ‘reset’ to 
maintain the high rather than a normal blood pressure. 
 
b.Increased sympathetic activity : 
This mechanism mainly works through adrengic receptors 
    Namely α and β receptors.  These are present in post ganglionic sympathetic nerve 
endings. A  receptors are further classified into α1 and α2. α1 receptors present in the 
vascular smooth muscle leads to constriction. α2 receptors are present in the human 
   leucocytes and platelets and it helps to release renin from the kidney. Receptors are 
further classified into β1 and β2. β1 receptors present in the heart, increases the force 
and rate of contraction.. β2 receptor  present in the bronchus leads to relaxation of 
bronchus. 
 
c.Ischaemic response of the C.N.S : 
   Ischaemic leads to sensitisation of vasomotor centre.  When B.P falls very low 
below 90mm, the V.M.C produces vasocontriction of vessels throughout the body. 
Thereby the B.P will be raised. 
 
2. Renal Mechanism :(Long-Term Regulation) 
    Kidneys regulate blood pressure various mechanisms. 
The important are; 
a. Extracellular Fluid Volume theory. 
b.Salt retention theory. 
c. Renin Angiotensin theory and Renin Angiotensin-aldosterone theory. 
 
a). ECF volume Theory: 
     When the blood pressure increase , kidney excrete large amounts of water and 
salts, particularly sodium by means of pressure diuresis and pressure natriuresis. 
Pressure dieresis is the excretion of  large quantity of water in urine because of 
increase blood pressure. Even a slight increased blood pressure doubles of water 
excretion. Pressure natriuresis is the excretion of large quantity of sodium in urine. 
    Because of diuresis and natriuresis there is decrease in the ECF volume and blood 
volume ,which in turn bring s the arterial blood pressure  back to normal level. 
  When blood pressure decrease, the reabsortion of water from renal tubulels in 
increased. This in turn,increase  ECF volume, blood volumevolume and cardiac 
output resulting in restoration of  blood pressure. 
a. Salt Retention Theory : 
    Due to Increased intake of sodium content in salt leads to increase in extra cellular 
fluid which in turn raises blood volume it leads to increased arterial  blood pressure. 
Increased salt intake 
 
Increased extra cellular volume 
 
Increased arterial pressure 
 
The hormones concerned in the regulation of B.P are 
a) Catecholamines( adrenaline and nor-adrenaline) 
b) Aldosterone 
c) Vasopressin 
a.Catecholamines, adrenaline and nor-adrenline : 
    These are excessively secreted during stress and strain which in turn leads to 
stimulation of adrenergic receptors.  It leads to increased Blood Pressure. 
b.Aldosterone : 
   Aldosterone  causes retention of sodium and water thereby increase 
the and blood volume. Thus, an increase in the secretion of aldosterone  
increase the blood pressure by increase blood volume. 
 
 
 
c.Vasopressin : 
   It is otherwise called as antidiuretiric  hormone   has a potent action on the blood 
Vessels  particularly the arteries. It causes constriction of the blood  vessels, then 
increase blood pressure. 
 
MEASUREMENT OF BLOOD PRESSURE 
 
Mercury Sphygmomanometer: 
   Here  the  pressure  changes  are  reflected  by  a  rise  of  mercury.  It is an accurate  
method of  taking  Blood  pressure.  However, the instrument is bulky and heavy. 
 
Technique : 
1. Clothing  should  be  removed  from  the  arm.  If  it  cannot be removed, it is 
better. To leave it as it is, rather than fold the clothing into tight constricting bands. 
2. The cuff should be encircled around the arm.  If the bladder does not encircle the 
arm completely, the centre of the bladder should be over the brachial artery. The 
rubber tubes from the bladder are usually placed inferiorly at the site of the brachial 
artery, but it would be better to place it superiorly or posteriorly so that the antecubital 
fossa is easily for ausculation. 
3. The bell gives better sound reproduction but a diaphragm is easier to secure with 
the finger of one’s hand and covers a large area. 
4. To measure Blood Pressure in the legs a thigh cuff containing large bladder(18*24 
cms) for adults should be wrapped around the thigh of the prone patient and the 
korotkoff sounds auscultated in the popliteal fossa in the usual way.  Blood Pressure 
in the legs is equal to that in the arms provided the bladder is adequate in size. 
5. For children, pediatric size cuff should be used. 
 
Precautions : 
1. Explain the procedure to the patient to allay anxiety. 
2. Avoid exertion, meals or smoking for 30 minutes before Blood Pressure is 
measured.  The patient must be allowed to rest for 5 minutes before Blood 
Pressure is measured. He should not have consumed coffee, tea for the 
preceding one hour or smoked for the preceding 15 minutes. He should no 
bladder distension. 
3. The room should be warm and quiet. 
4. High Blood Pressure may be erroneously recorded in an obese person because the 
inflatable rubber bladder may be too short for the obese arm (recommended 
dimensions are 12 * 35 cms).  When  the  bladder  does  not 
completely encircle the arm the centre of the bladder must be placed directly 
over the brachial artery. 
5. The arm must be supported to the heart level.  In the supine position the arm is 
usually at the heart level.  In sitting and standing positions the arm must be horizontal 
with fourth intercostal space at the heart level.  Some antihypertensive agents cause 
postural hypotension and when this is expected, Blood Pressure must be measured in 
both lying and standing positions. 
6. It is desirable to record the Blood Pressure in both the arms as the differences in 
systolic pressure exceeding 10 mm Hg between the two arms when measured 
simultaneously or in rapid sequence suggest obstructive lesions of aorta, innominate 
or subclavian arteries. 
7. In vertebrobasilar insufficiency, a difference in pressure between the arms 
may signify that a subclavian steal is responsible for cerebrovascular 
symptoms. 
8. Normally systolic pressure in the legs is up to 20 mm Hg higher than in the 
arms, but diastolic Blood Pressure is the same.When systolic pressure in the 
popliteal artery exceeds that in brachial artery by > 20 mm Hg (Hill's sign), 
AR is usually present. 
9. Measuring lower limb Blood Pressure is useful in detecting coarctation of 
aorta or obstructive disease of the aorta  or its immediate branches.. 
10. The Blood Pressure may be higher in right arm by 2-10 mm Hg.  Most 
pressures in practice are measured on the right arm.  However if the Blood 
Pressure is higher by 10 mm Hg in one arm further measurements should be 
made  in   that arm. 
11. The cuff should be snugly fitted to the arm.  A cuff which is too tight may give a 
false lower blood pressure and a loose cuff may give a false higher Blood Pressure. 
12. Repeated inflation of the cuff may cause venous congestion of the limb and 
elevate both systolic and diastolic Blood Pressure.  To avoid this  the cuff should be 
inflated as rapidly as possible and deflated completely between successive readings 
.At least 15 seconds should be allowed between successive  measurements. 
 
Clinical features : 
Symptoms : 
Most of the patients are asymptomatic 
 Occipital headache usually in the early morning. 
 Giddiness. 
 Palpitation. 
 Breathlessness 
 Easy fatigability. 
 Lack of concentration. 
 Insomnia. 
 Flashes of light before the eyes. 
 Epistaxis. 
 
Basic Investigations : 
Blood:   TC ,DC,ESR,Hb 
              Blood Sugar –Randum 
Serum cholesterol 
Blood Urea 
Serum Creatinine 
Urinalysis: Albumin,Sugar,Deposit 
Specific Investigation: 
Blood pressure monitoring 
Electrocardiogram 
Lipid profile 
Chest x-Ray 
 
Prevention and management of Hypertension: 
1. The goal of anti hypertension therapy is the reduction of cardiovascular and renal 
morbidity  and  mortality, with focus on controlling the systolic blood pressure ,as 
most patients  will  achieve diastolic blood  pressure control when the systolic blood 
pressure is  achieved. 
2. In the patients younger than 80 years, the systolic  blood  pressure target should be 
140 to 150mmHg  ,patients  with diabetes should be treated to blow 85mmHg 
diastolic Blood  pressure. 3. Body Mass Index (MBI)should be reduced to 25 kg/m2. 
4. Patients was advised  to avoid the food which increases the pitthakutram  and to  
avoid bitter guard sesbania leaves, which interfere the action of  drug 
.5. Diet restriction is needed to prevent hypertension, fat content of diet should be low 
and saturated fat was avised. 
6. Cessation of Alcohol, cigratte smoking and excessive use of Tea, Coffee, needed to 
check. 
7. Patients  were  advised to maintaining a normal sleep pattern to get rid of stress. 
8. Patients were advised to take Garlic and vitamin –E containing diet due to their 
Anti cholesterol  actions. 
9. Aerobic exercise for 15-20 minutes help in the management of associated Cardiac 
risk factors. 
 
Treatment: 
     There is no cure for primary hypertension, but blood pressure can almost always be 
lowered with the correct treatment. The goal of treatment is to lower blood pressure to 
levels that will prevent heart disease and other complications of hypertension. In 
secondary hypertension, the disease that is responsible for the hypertension is treated 
in addition to the hypertension itself. Successful treatment of the underlying disorder 
may cure the secondary hypertension. 
    Guidelines advise that clinicians work with patients to agree on blood pressure 
goals and develop a treatment plan for the individual patient. Actual combinations of 
medications and lifestyle changes will vary from one person to the next. Treatment to 
lower blood pressure may include changes in diet, getting regular exercise, and taking 
antihypertensive medications. Patients falling into the pre-hypertension range who 
don't have damage to the heart or kidneys often are advised to make needed lifestyle 
changes only. A 2003 report of a clinical trial showed that adults with elevated blood 
pressures lowered them as mush as 38% by making lifestyle changes and participating 
in the DASH diet, which encourages eating more fruit and vegetables. 
Lifestyle changes that may reduce blood pressure by about 5 to 10 mm Hg include: 
 reducing salt intake 
 reducing fat intake 
 losing weight 
 getting regular exercise 
 quitting smoking 
 reducing alcohol consumption 
 managing stress 
     Patients whose blood pressure falls into the Stage 1 hypertension range may be 
advised to take antihypertensive medication. Numerous drugs have been developed to 
treat hypertension. The choice of medication will depend on the stage of hypertension, 
side effects, other medical conditions the patient may have, and other medicines the 
patient is taking. 
 
   If treatment with a single medicine fails to lower blood pressure enough, a different 
medicine may be tried or another medicine may be added to the first. Patients with 
more severe hypertension may initially be given a combination of medicines to 
control their hypertension. Combining antihypertensive medicines with different types 
of action often controls blood pressure with smaller doses of each drug than would be 
needed for just one. 
Anti hypertensive medicines fall into several classes of drugs: 
 Diuretics 
 Beta-blockers 
 Calcium channel blockers 
 Angiotensin converting enzyme inhibitors (ACE inhibitors) 
 Alpha-blockers 
 Alpha-beta blockers 
 Vasodilators 
 Peripheral acting adrenergic antagonists 
 Centrally acting agonists 
      Diuretics help the kidneys eliminate excess salt and water from the body's tissues 
and the blood. This helps reduce the swelling caused by fluid buildup in the tissues. 
The reduction of fluid dilates the walls of arteries and lowers blood pressure. New 
guidelines released in 2003 suggest diuretics as the first drug of choice for most 
patients with high blood pressure and as part of any multi-drug combination. 
Beta-blockers lower blood pressure by acting on the nervous system to slow the heart 
rate and reduce the force of the heart's contraction. They are used with caution in 
patients with heart failure, asthma, diabetes, or circulation problems in the hands and 
feet. 
    Calcium channel blockers block the entry of calcium into muscle cells in artery 
walls. Muscle cells need calcium to constrict, so reducing their calcium keeps them 
more relaxed and lowers blood pressure. 
   ACE inhibitors block the production of substances that constrict blood vessels. They 
also help reduce the build-up of water and salt in the tissues. They often are given to 
patients with heart failure, kidney disease, or diabetes. ACE inhibitors may be used 
together with diuretics. 
   Alpha-blockers act on the nervous system to dilate arteries and reduce the force of 
the heart's contractions. 
 Alpha-beta blockers combine the actions of alpha and beta blockers. 
  Vasodilators act directly on arteries to relax their walls so blood can move more 
easily through them. They lower blood pressure rapidly and are injected in 
hypertensive emergencies when patients have dangerously high blood pressure. 
Peripheral acting adrenergic antagonists act on the nervous system to relax arteries 
and reduce the force of the heart's contractions. They usually are prescribed together 
with a diuretic. Peripheral acting adrenergic 
   Centrally acting agonists also act on the nervous system to relax arteries and slow 
the heart rate. They are usually used with other antihypertensive medicines. 
 
 
Prognosis: 
    There is no cure for hypertension. However, it can be well controlled with the 
proper treatment. Therapy with a combination of lifestyle changes and 
antihypertensive medicines usually can keep blood pressure at levels that will not 
cause damage to the heart or other organs. The key to avoiding serious complications 
of hypertension is to detect and treat it before damage occurs. Because 
antihypertensive medicines control blood pressure, but do not cure it, patients must 
continue taking the medications to maintain reduced blood pressure levels and avoid 
complications. 
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TRIAL DRUG 
PUDHINA THEENEER 
INGREDIANTS: 
 Puthina leaves (Mentha arvensis) 
 Water 
 
PREPARATION :- 
 The shade dried leaves of pudhina (800 gms) are put in the mud pot add 6000 
ml of water and keep aside in one night 
 Next day will transfer into the theeneer valai instrument making 3000 ml of 
theeneer 
 
DOSAGE     :-  15 – 35 ml, 2-3 times daily before food. 
DURATION :-  48 Days (1 mandalam) 
 
REFERENCE:  Sigicha  Rathna  Deepam– Part-1 
Kannusamy  Pillai-Rathna  Naayakar & Sons 
Thanjavur. 
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MATERIALS AND METHODS 
 
STUDY DESIGN: 
     The open clinical trial on URATHA PITHAM (Hypertension) was conducted at 
the OPD section of postgraduate, pothu  maruthuvam department attached to Arignar 
Anna hospital of Indian medicine, chennai-106, during the period 2014- 2017. 
STUDY CENTRE: 
    The entire study was conducted on patients at out patient Department of Govt 
Siddha Medical college, Chennai in the premises of Arignar Anna Government 
Hospital for Indian medicine and Homeopathy,Arumbakkam,Chennai-106,during the 
period of 2015-2017. 
SAMPLE SIZE: 
The sample size was 40 patients. 
INCLUSION CRITERIA 
 Age 18-60 years 
 Blood pressure level above 140/90mm Hg and 180/100mmHg 
 Fatigue 
 Nausea 
 Insomnia 
 Giddiness 
 Palpitation 
 Headache 
 Sweating 
 Obesity 
 
 
 
EXCLUSION CRITERIA 
       Age group less than 18 and above 60 years 
 K/C/O Hypertension in pregnancy 
 K/C/O Associated other secondary diseases like renal failure, CCF,                                     
other  cardiac   problems, chronic diseases 
 K/C/O Diabetes mellitus. 
 Blood pressure level below 140/90mmHg and above 180/100mmHg 
 
WITH DRAWAL CRITERIA 
 Development of severe adverse drug reactions 
 Occurrence of  any other serious illness 
 Patients turned unwilling to continue in the course of clinical trial 
 
EVALUATION OF CLINICAL PARAMETERS: 
Patients are clinically evaluated by following parameters 
. 
HISTORY TAKING: 
     Age, Occupation, Socio economic status, Complaints and duration, Previous 
illness, Family history, Personal habits were recorder in the case sheet for every 
patient at the time of first visit to the OP 
 
INVESTIGATIONS: 
Blood: 
 TC, 
 DC, 
 ESR, 
 Hb 
 Blood sugar (Random) 
 Blood Urea, 
 Serum Creatinine 
 
Urine: 
 Albumin, 
 Sugar, 
 Deposit 
Specific Investigations: 
 BP Monitoring 
 Electrocardiogram 
 Lipid profile 
 X-ray chest 
 
CLINICAL DIAGNOSIS BASED ON SIDDHA SYSTEM : 
The parameters used to diagnose the disease Uratha pitham based on siddha system 
are: 
 Poriaalaridhal 
 Pulanaalaridhal 
 Vinaadhal 
 Uyirthathukkal 
 Udalthathukkal 
Envagaithervu: Naa, Niram, Mozhi, Vizhi, Sparisam, Malam, Moothiram,  
 Naadi. 
 
Neerkuri: Niram,Manam, Nurai, Enjal, Edai 
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RESULTS AND OBSERVATION 
A total number of 40 patients included in the study with signs and symptoms  of 
Uratha pitham were selected and treated from PG Maruthuvam  Department  Govt  
Siddha Medical College, Chennai – 106  during the period of 2014-2017 
The observations were tabulated regarding the following conditions. 
1. Age Distribution 
2. Sex Distribution 
3. Thinai Distribution 
4. Kaalam Distribution 
5. Occupational status 
6. Socio economic stastus 
7. Food habits 
8. Personal habits 
9. Clinical Symptoms 
10. Distribution of Vatham 
11. Distribution of Pitham 
12. Distribution of Kabam 
13. EzhuUdalKattugal 
14. EnvagaiThervugal 
15. Naadi nadai 
16. Neikuri 
17. Clinical progress 
18. Effect on Blood Pressure 
19. Results 
 
 
1.AGE DISTRIBUTION 
AGE IN YEARS NO OF CASES PERCENTAGE 
30 - 40 
41- 50 
51- 60 
4 
13 
23 
10% 
32.5% 
57.5% 
 
AGE DISTRIBUTION 
                        
                       Inference: 
   Out of 40 patients, majority of the cases that is 23(57.5%) were in                             
51-60 years age group, 32.5% were in 41-50 years age group 10% of 
cases were in 30-40 years age group. 
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2.SEX DISTRIBUTION 
 
 
 
 
 
SEX DISTRIBUTION 
                          
                       Inference: 
    Out of 40 patients, majority of the cases that is 24(60%) 
were female  and  minority of  the  cases  that is 16(40%) were  male. 
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AGE IN YEARS No. OF CASES PERCENTAGE 
Male 16 40% 
Femal 24 60% 
3.DISTRIBUTION OF THINAI 
 
THINAI NO.OF 
CASES 
PERCENTAGE 
KURINIJI 0 0% 
MULLAI 0 0% 
MARUHAM 27 67.5% 
NEITHAL 13 32.5% 
PALAI 0 0% 
 
 
 
 
 
                   Inference: 
    Out of 40 patients, 27(67.5%) comes under Marutham and 
13(32.5%)  comes under Neithal. 
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4.DISTRIBUTION OF KAALAM 
 
        
        Inference: 
   As per Tamil seasonal classification highest incidence of 37.5% (15) of 
cases were noted in Koothir kaalam, 25% (10) cases were noted in pinpani 
kaalam, 17.5% (7) of cases were noted in Munpani kaalam, 12.5% (5) of cases 
were noted in Kaar kaalam, 5% (2) of cases were noted in Mudhuvenil kaalam 
and 2.5 (1) of cases were noted in Elavenil kaalam. 
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KALLAM MONTH(MAADHAM) NO  OF 
CASES 
PERCENTAGE 
Kaar Kaalam (Avani-purattasi)     (Aug 
16 – Oct 15) 
5 12.5% 
Koothir Kaalam (Aippasi-Karthigai) (Oct 
16 – Dec 15 
15 37.5% 
Munpani Kaalam (Maarazhi – Thai) (Dec 16 
– Feb 15 
7 17.5% 
Pinpani Kaalam (Masi – Panguni) (Feb 16 
– Apr 15 
10 25% 
Elavenil Kaalam (Chithirai – Vaikasi) (Apr 
15 – Jun 15 
1 2.5% 
Mudhuvenil 
Kaalam 
Aani – Aadi) (June 16 – 
Aug 15 
2 5% 
5.OCCUPATIONAL STATUS 
NATURE OF WORK NO. OF CASES PERCENTAGE 
Labour 8 20% 
Retired persons 9 22.5% 
House – Wifes 13 32.5% 
Professionals 10 25% 
 
 
 
Inference: 
    Since  Occupational history is closely relatives with the exaggeration of the 
condition, detailed history was made and tabulated 20% were Labours, 
23% were retired persons, 32.5.% were House wifes and 25% were professionals. 
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 6.SOCIO ECONOMIC STATUS 
NATUR OF WORK NO OF CASES PERCENTAGE 
Low Income group (upto 
Rs.2,00,000/Annum) 
18 45% 
Middle Income group 
(Rs.2,00,000 – 
5,00,000/Annum) 
14 35% 
High Income group (Above 
Rs.5,00,000/Annum) 
8 20% 
 
            
          Inference: 
    Out of 40 cases majority cases were recorded in low income group (45%), 
35% cases from middle Income group and 20% cases from High Income 
group. 
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7.DIETARY HABITS 
DIETARY HABITS NO.OF CASES PERCENTAGE 
VEGETARIAN 7 17.5% 
MIXED 33 82.5% 
 
 
          
         Inference: 
Out of 40 patients, 33 (82.5%) patients were Consumed mixed diet and 7 
patients (17.5%) were consumed Vegetarian diet. 
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8.PERSONAL HABITS 
PERSONAL HABITS NO.OF CASES PERCENTAGE 
Smokers 5 
 
12.5% 
Alcoholics 6 15% 
Tobacco Chewing 1 2.5% 
Mixed 11 27.5% 
No Habits 17 42.5% 
 
              
Inference: 
Out of 40 patients, 5(12.5%) patients were Smoking, 6(15%) were Alcoholics, 
1(2.5%) were Tobocco chewing, 11(27.5) were Mixed habits and 17(42.5%) 
were no Habits. 
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9.SYMPTOMS 
SYMPTOMS NO. OF CASES PERCENTAGE 
Insomnia 17 42.5% 
Giddiness 7 17.5% 
Headache 3 7.5% 
Palpitation 4 10% 
No Symptoms 9 22.5% 
 
                
Inference: 
      Out of 40 patients, 17 patients (42.5%) were affected Insomnia, 7(17.5%) 
patients were affected Giddiness, 3(7.5%) patient affected Head ache, 4(10%) 
patients affected palpitation and 9(22.5%) no symptoms. 
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10.DISTRIBUTION OF VATHAM 
VATHAM NO.OF CASES PERCENTAGE 
Pranan 7 17.5% 
Abanan 
 
0 0% 
Viyanan 40 100% 
 
Samanan 0 0% 
Uthanan 0 0% 
Nagan 0 0% 
Koorman 5 12.5% 
Kirukaran 0 0% 
Devathathan 17 42.5% 
Thananjeyan 0 0% 
 
         
        Inference: 
   Pranan affected 7(17.5%), Viyanan affected in all patients (100%), Koorman 
affected 13% and Devathathan affected in 17 patients (42.5.%). 
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   11 .DISTRIBUTION OF PITHAM 
PITHAM NO.OF CASES PERCENTAGE 
Analagam 0 0% 
Ranjagam 
 
0 0% 
Sathagam 23 57.5% 
 
Pirasagam 0 0% 
Alosagam 5 12.5% 
 
 
             
Inference: 
Pranan affected 7(17.5%), Viyanan affected in all patients (100%), Koorman 
affected 13% and Devathathan affected in 17 patients (42.5.%). 
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12 .DISTRIBUTION OF KABAM 
KABAM NO.OF CASES PERCENTAGE 
Avalambagam 7 17.5% 
Kilethagam 
 
0 0% 
Pothagam 0 0% 
 
Tharpagam 0 0% 
Santhigam 9 22.5% 
 
          
         Inference: 
  Out of 40 Patients, Avalamagam affected in 6 (15%) patients, Santhigam  
affected    in 9 (22.5%) patients. 
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  13 .EZHU UDAL THATHUKKAL 
EZHUUDAL 
THATHUKKAL 
NO.OF 
CASES 
PERCENTAGE 
Saram 40 100% 
Seneer 
 
40 100% 
Oon 0 0% 
 
Kozbuppu 0 0% 
Enbu 9 22.5% 
Moolai 0 0% 
Sukilam 0 0% 
 
        
     Inference: 
                       Out of 40 patients, Saram and Seneer affected in all patients (100%)and 
         enbu were affected in 22.5%. 
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14 .ENN VAGAI THERVUGAL 
ENNVAGAI 
THERVUGAL 
NO. OF CASES PERCENTAGE 
Naa 0 0% 
Niram 
 
0 0% 
Mozhi 0 0% 
 
Vizhi 5 12.5% 
Sparism 0 0% 
Malam 0 0% 
Moothiram 0 0% 
Naadi 40 100% 
 
             
Inference: 
     Vizhi were affected in 5(12.5%) patients, Naadi affected in all patients. 
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15.NAADI 
NAADI NO.OF CASES PERCENTAGE 
Vaatham 5 12.5% 
Vathapitham 
 
26 65% 
Pithavatham 7 17.5% 
 
Kabapitham 1 2.5% 
Kaba vatham 1 2.5% 
 
                
Inference: 
26 (65%) of cases had Vathapitham Naadi, 7 (17.5%) of cases had pitha 
Vatham, 5 (12.5%) of cases had Vatham, each 1 (2.5%) of cases had kaba 
pitham and kaba vatham. 
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                                       16.NEIKURI 
NEIKURI NO. OF CASES PERCENTAGE 
Vatham (Snake like) 30 75% 
Pitham (Ring like) 
 
10 25% 
Kabam (Pearl like) 0 0% 
 
 
               
Inference: 
Out of 40 patients, 30 patients (75%) had Vatha Neer, 10 (25%) had Pitha 
Neer. 
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17.CLINICAL PROGRESS 
Sl.No. SYMPTOMS 
No. OF CASES PERCENTAGE (%) 
BT AT BT AT 
1 Insomnia 21 10 52.50% 25% 
2 Giddiness 15 7 37.50% 17.50% 
3 Head ache 3 0 7.5% 0% 
4 Palpitation 6 1 15% 2.50% 
5 No Symptoms 20 24 50% 60% 
CLINICAL PROGRESS 
              
         Inference: 
     Insomnia were affected in 21 (52.5%) patients before treatment and   after 
treatment it was improved in 10 (25%) Giddiness were affected 15 (37.5%) 
patients in before treatment and after treatment it was improved in 7 (17.5%) 
patients, Head ache were affected 3 (7.5%) patients in before treatment and 
after treatment, it was improve 0% patients. Palpitation is were affected 6 
(15%) patients in before treatment and after treatment it was improved 1 
(2.5%) patients. 
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18 .EFFECT ON BLOOD PRESSURE 
Sl.No. HYPERTENSION 
No. OF CASES PERCENTAGE (%) 
BT AT BT AT 
1 
Mild (120-129/80-
89mmHg) 10 29 25% 72.5% 
2 
Moderate (140 mm 
Hg) 28 14 70% 35% 
3 
Severe (>180-
110mm Hg) 0 0 0% 0% 
 
EFFECT ON BLOOD PRESSURE 
                   
Inference: 
      Out of the 40 patients, Mild affected patients 10 (25%) in before treatment 
and after treatment 29 (72.5%) patients were improved and moderate affected 
patients 28 (70%) in before treatment and after treatment 14 (35%) were 
improved. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Mild
Moderate
Severe
25%
70%
0%
73%
35%
0%
Mild
Moderate
Severe
   19 .GRADING OF RESULTS 
Sl.No. HYPERTENSION 
No. OF 
CASES 
PERCENTAGE 
(%) 
BT AT BT AT 
1 
Mild (120-129/80-
89mmHg) 10 29 25% 72.5% 
2 
Moderate (140 mm 
Hg) 28 14 70% 35% 
3 
Severe (>180-
110mm Hg) 0 0 0% 0% 
                      
  Inference: 
            Out of 40 patients, 29 (72.5%) shows good result, 8 cases (20%) shows 
moderate results, 3 cases (7.5%) shows poor result. 
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LABORATORY INVESTIGATION REPORT OF THE PATIENTS 
Sl. No. O.P No. Age / Sex 
Before Treatment After Treatment ESR (mm) Hb                              (gms%) Urine Analysis 
TC DC TC DC BT AT BT AT BT AT 
Cu/mm P                % 
L          
% 
E              
% Cu/mm 
P                
% 
L 
% 
E              
% 
1/2
Hr 
1       
Hr 
1/2 
Hr 
1       
Hr     Alb Sug Dep Alb Sug Dep 
1 3176 52/F 7400 70 24 6 8100 65 25 4 18 38 15 32 14.6 15.1 N N FP N N FP 
2 9994 45/F 7100 55 32 8 7200 61 30 6 14 30 17 35 7.1 10.5 N N FE N N FE 
3 1153 60/M 8800 53 38 9 8100 50 28 5 3 10 5 10 9.4 11 N N FP N N FE 
4 822 55/F 6700 65 29 6 7200 58 30 3 12 20 11 15 12.5 13 N N FP N N FP 
5 2486 45/F 7800 74 32 2 9200 65 28 4 20 30 15 30 11 11.5 N N FE N N FE 
6 4973 60/F 6900 64 32 4 7200 56 22 5 15 32 10 20 12.9 12 N N FE N N FE 
7 5059 37/F 7500 51 41 8 7300 48 35 4 13 22 11 15 11.7 13 N N FP N N FP 
8 4694 58/M 8200 59 38 4 8500 59 36 7 5 8 7 9 13.5 15 N N FE N N FE 
9 2221 58/M 9100 64 30 4 9200 53 32 7 3 7 5 8 10.6 12 N N FP N N FE 
10 823 49/F 8800 55 37 6 9100 51 37 8 11 15 7 12 11.5 13 N N FE N N FE 
11 9320 45/F 7700 61 28 7 8200 56 32 5 7 12 5 7 8.6 7.5 N N FE N N FP 
12 3189 50/M 9200 60 35 3 8500 52 41 4 3 10 7 13 12 13.5 N N FP N N FP 
13 842 60/F 9900 71 40 8 9600 67 30 9 11 20 8 15 9.8 11 N N FE N N FE 
14 9364 55/M 8700 57 31 7 9100 62 35 8 4 8 6 21 13 13 N N FE N N FE 
15 1412 48/M 10100 65 34 5 9800 55 37 9 6 10 6 13 9 11 N N FP N N FP 
16 2260 60/F 9400 72 41 9 9500 68 37 9 12 21 11 17 11.5 12 N N FE N N FP 
17 7915 55/F 8200 58 29 6 9200 57 32 9 15 35 12 31 13 12.5 N N FP N N FE 
18 8127 50/F 7900 97 41 8 8500 69 38 8 12 22 12 19 8.5 10 N N FE N N FE 
19 1286 60/F 9100 56 34 5 9200 61 27 7 14 25 11 25 10 11 N N FP N N FE 
20 5156 55/M 10600 61 31 6 10000 58 35 4 35 23 27 51 11.5 12 N N FE N N FE 
 
 
BT – Before Treatment, AT – After Treatment, N – Nil, TC – Total Blood Count, DC – Differential Blood Count,                         
P –Polymorphslymorphs, L – Leucocytes, E – Eosinophils,  ESR – Erythrocytes Sedimentation Rate, mm – Milli meter          
Hb – Hemoglobin, Alb – Albumin, Sug – Sugar, Dep– Deposits, FE – Few Epithelial cells, FP – Few Pus cells 
 
  
BT – Before Treatment, AT – After Treatment, N – Nil, TC – Total Blood Count, DC – Differential Blood Count,         P –Polymorphslymorphs, L – Leucocytes, 
E – Eosinophils,  ESR – Erythrocytes Sedimentation Rate, mm – Milli meter           Hb – Hemoglobin, Alb – Albumin, Sug – Sugar, Dep– Deposits, FE – Few 
Epithelial cells, FP – Few Pus cells 
 
LABORATORY INVESTIGATION REPORT OF THE PATIENTS 
Sl. No. O.P No. Age / Sex 
Before Treatment After Treatment ESR (mm) Hb                              (gms%) Urine Analysis 
TC DC TC DC BT AT BT AT BT AT 
Cu/mm P                % 
L          
% 
E              
% Cu/mm 
P                
% 
L          
% 
E              
% 
1/2 
Hr 
1       
Hr 
1/2 
Hr 
1       
Hr     Alb Sug Dep Alb Sug Dep 
21 5244 31/M 10600 57 27 5 9500 56 27 6 20 40 16 31 12 11 N N FP N N FP 
22 5155 50/F 9400 65 29 6 9400 62 27 5 21 42 15 29 13 11.5 N N FP N N FE 
23 6308 56/F 8000 54 31 4 9200 54 35 5 2 4 2 5 13 11 N N FE N N FE 
24 3245 55/F 10200 61 31 5 10100 62 33 5 30 50 21 40 14 14.5 N N FE N N FE 
25 4171 60/M 7100 59 35 1 8300 58 39 2 5 8 3 9 10 11.5 N N FP N N FP 
26 5068 40/M 8900 61 33 7 8600 60 37 6 4 9 5 17 13 14 N N FE N N FP 
27 5114 55/M 8500 53 34 4 9000 54 31 7 21 38 20 40 12 11 N N FP N N FE 
28 4624 53/F 9700 65 30 3 9700 64 31 5 25 48 19 41 13.6 12.5 N N FE N N FP 
29 1656 55/F 8200 71 32 8 9100 68 41 7 17 28 12 31 14.2 13 N N FP N N FE 
30 7616 52/F 7900 67 40 9 8000 64 37 8 36 74 28 53 11.8 13 N N FE N N FE 
31 1152 60/F 9500 61 33 9 9700 61 40 7 15 25 11 28 12 12.8 N N FE N N FP 
32 1713 50/F 8900 70 45 3 8500 65 41 7 13 21 13 28 12 14 N N FP N N FP 
33 9147 35/M 7100 59 33 8 8300 64 29 4 22 38 15 25 10 11.5 N N FE N N FP 
34 9033 58/M 10200 67 38 5 9800 67 41 3 15 29 19 30 12 13 N N FP N N FE 
35 5157 50/M 9300 56 27 9 9300 63 28 9 30 58 23 41 13 11.5 N N FP N N FP 
36 2413 47/F 8100 60 34 4 7900 61 13 7 20 40 15 30 10.4 11.5 N N FE N N FE 
37 5275 49/F 7800 73 39 9 7500 71 29 6 13 26 18 40 9.5 12 N N FP N N FP 
38 6642 55/M 10100 61 31 7 10000 55 32 8 17 30 21 45 8.6 10 N N FE N N FP 
39 1659 50/F 9100 70 28 8 8500 71 28 8 30 56 23 41 9 11 N N FP N N FE 
40 387 54/M 8000 57 26 3 9200 57 28 5 36 72 25 50 12 12.5 N N FE N N FE 
  
 
BIO CHEMICAL REPORTS OF THE PATIENTS 
Sl. 
No. 
O.P No. Age / Sex 
Blood Sugar Blood Urea 
Serum 
Cholosterol 
Serum 
Creatinine 
BT AT BT AT BT AT BT AT 
1 3176 52/F 90 100 21.3 21 190 179 0.7 0.8 
2 9994 45/F 138 110 15 13 155 130 1.2 1.0 
3 1153 60/M 75 90 28 23 168 173 1.0 1.1 
4 822 55/F 142 110 22 19 160 130 1.1 1.0 
5 2486 45/F 90 110 34 38 190 192 0.7 0.9 
6 4973 60/F 134 124 23 23 153 150 0.6 0.6 
7 5059 37/F 65 90 25 29 156 161 0.6 0.9 
8 4694 58/M 87 96 29 28 170 172 0.9 1.1 
9 2221 58/M 127 120 32 30 163 171 0.8 0.9 
10 823 49/F 78 85 27 28 178 173 1.0 1.0 
11 9320 45/F 85 80 23 27 180 181 0.8 1.0 
12 3189 50/M 89 90 31 34 192 195 1.1 1.0 
13 842 60/F 82 95 29 31 155 158 0.6 0.9 
14 9364 55/M 80 92 20 21 148 139 1.2 1.0 
15 1412 48/M 81 87 16 19 173 168 0.9 0.7 
16 2260 60/F 108 115 23 25 169 160 1.0 1.0 
17 7915 55/F 100 112 35 33 210 181 1.2 1.0 
18 8127 50/F 116 123 28 26 196 182 0.9 0.7 
19 1286 60/F 72 81 15 13 174 167 0.8 0.6 
20 5156 55/M 110 115 21 22 167 158 1.0 0.9 
 
 
 
  
 
BIO CHEMICAL REPORTS OF THE PATIENTS 
Sl. No. O.P No. Age / Sex 
Blood Sugar Blood Urea 
Serum 
Cholosterol 
Serum 
Creatinine 
BT AT BT AT BT AT BT AT 
21 5244 31/M 70 90 16.1 14 163 141 1.1 1.0 
22 5155 50/F 126 121 15 17 149 131 1.1 1.0 
23 6308 56/F 83 81 16 16 186 175 0.9 0.8 
24 3245 55/F 71 86 28 26 174 167 1.0 1.0 
25 4171 60/M 137 142 21 19 190 181 0.9 0.9 
26 5068 40/M 85 87 20 17 144 138 1.2 1.0 
27 5114 55/M 78 91 19 15 178 161 0.8 0.6 
28 4624 53/F 95 87 29 25 170 172 0.9 1.0 
29 1656 55/F 89 95 33 37 193 186 0.8 0.7 
30 7616 52/F 76 90 29 31 157 160 0.7 0.9 
31 1152 60/F 62 75 34 36 160 167 1.0 1.2 
32 1713 50/F 138 110 37 28 186 172 1.1 1.0 
33 9147 35/M 120 72 21 24 169 161 0.8 0.7 
34 9033 58/M 62 78 31 35 155 149 0.7 1.0 
35 5157 50/M 96 110 29 32 190 193 0.9 0.8 
36 2413 47/F 87 96 31 31 18 178 1.0 1.1 
37 5275 49/F 91 100 25 30 148 156 0.6 0.8 
38 6642 55/M 78 112 20 26 167 170 1.0 0.9 
39 1659 50/F 110 100 19 23 176 183 1.0 1.1 
40 387 54/M 128 120 32 33 165 171 0.9 1.2 
 
 
 
  
 
LIPID PROFILE 
Sl. No. O.P No. Age / Sex 
Before Treatment After Treatment 
HDL LDL VLDL TGL 
HDL       LDL    
Ratio 
HDL LDL VLDL TGL 
HDL       LDL    
Ratio 
1 3176 52/F 47.6 131 21 139 5.2 45 129 24 141 5.1 
2 9994 45/F 35 130 19 213 5.1 40 125 17 190 5.0 
3 1153 60/M 39 151 23 187 5.3 39 146 20 185 5.1 
4 822 55/F 37 136 29 142 5.3 34 130 25 138 5.1 
5 2486 45/F 41 151 30 161 5.2 37 141 27 157 5.1 
6 4973 60/F 54 145 36 167 5.4 47 130 32 161 5.2 
7 5059 37/F 57 141 34 164 5.3 49 131 33 160 5.2 
8 4694 58/M 60 159 35 183 5.4 60 149 31 172 5.1 
9 2221 58/M 58 155 32 194 5.3 61 153 33 178 5.5 
10 823 49/F 52 154 29 190 5.4 47 148 28 181 5.2 
11 9320 45/F 61 159 30 195 5.3 56 148 26 182 5.1 
12 3189 50/M 66 160 29 196 5.7 54 152 25 180 5.3 
13 842 60/F 51 158 28 207 5.2 56 147 32 186 5.3 
14 9364 55/M 48 151 30 160 5.4 41 143 30 155 5.2 
15 1412 48/M 50 148 29 150 5.5 37 140 28 150 5.1 
16 2260 60/F 55 152 31 198 5.3 57 150 28 190 5.3 
17 7915 55/F 38 130 27 140 5.1 36 126 26 138 5.0 
18 8127 50/F 49 145 31 180 5.3 46 143 27 176 5.2 
19 1286 60/F 56 158 30 220 5.5 52 154 28 180 5.2 
20 5156 55/M 53 156 28 191 5.3 50 150 31 182 5.1 
 
HDL – High Density Lipo protein LDL - Low density Lipo protein VLDL – Very Low Density Lipo protein 
  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
LIPID PROFILE 
Sl. No. O.P No. Age / Sex 
Before Treatment After Treatment 
HDL LDL VLDL TGL 
HDL       LDL    
Ratio 
HDL LDL VLDL TGL 
HDL       LDL    
Ratio 
21 5244 31/M 58 163 31 210 5.3 53 151 29 180 5.1 
22 5155 50/F 60 165 29 189 5.3 56 155 27 178 5.3 
23 6308 56/F 51 158 31 187 5.4 42 153 26 174 5.6 
24 3245 55/F 56 163 29 199 5.5 49 159 26 180 5.1 
25 4171 60/M 53 158 30 189 5.3 51 148 32 181 5.2 
26 5068 40/M 66 160 29 200 5.8 57 151 27 187 5.3 
27 5114 55/M 55 157 31 185 5.7 53 137 26 168 5.2 
28 4624 53/F 65 154 29 182 5.7 59 145 32 178 5.4 
29 1656 55/F 49 147 32 180 5.3 46 143 27 176 5.2 
30 7616 52/F 50 152 29 147 5.5 39 141 26 149 5.1 
31 1152 60/F 52 150 31 191 5.4 49 149 25 185 5.2 
32 1713 50/F 61 160 35 188 5.2 60 156 32 172 5.1 
33 9147 35/M 37 140 27 141 5.1 35 132 24 137 5.0 
34 9033 58/M 57 158 32 198 5.2 54 155 28 187 5.2 
35 5157 50/M 56 150 31 190 5.4 49 162 29 168 5.3 
36 2413 47/F 54 159 36 195 5.4 52 159 31 174 5.7 
37 5275 49/F 48 163 29 208 5.1 42 148 32 187 4.9 
38 6642 55/M 53 158 36 176 5.3 43 152 28 173 5.6 
39 1659 50/F 55 161 28 197 5.6 50 159 27 165 5.0 
40 387 54/M 52 152 33 191 5.2 49 152 25 169 5.1 
             
HDL – High Density Lipo protein LDL - Low density Lipo protein VLDL – Very Low Density Lipo protein 
  
 
 
 
 
 
 
 
BLOOD PRESSURE LEVEL 
Sl. 
No. 
O.P 
No. 
Age / 
Sex 
Blood Pressure 
RESULTS Before Treatment After Treatment 
SBP DBP SBP DBP 
1 3176 52/F 180 100 120 80 Good 
2 9994 45/F 160 100 140 90 Fair 
3 1153 60/M 160 100 150 100 Poor 
4 822 55/F 150 100 120 80 Good 
5 2486 45/F 140 95 130 80 Good 
6 4973 60/F 150 90 130 70 Good 
7 5059 37/F 140 100 120 70 Good 
8 4694 58/M 150 95 120 70 Good 
9 2221 58/M 150 95 130 70 Good 
10 823 49/F 140 90 120 70 Good 
11 9320 45/F 140 95 130 80 Good 
12 3189 50/M 155 100 120 80 Good 
13 842 60/F 150 90 130 70 Good 
14 9364 55/M 150 100 130 70 Good 
15 1412 48/M 140 90 120 70 Good 
16 2260 60/F 145 90 120 80 Good 
17 7915 55/F 150 100 130 70 Good 
18 8127 50/F 160 100 140 90 Fair 
19 1286 60/F 160 90 140 80 Fair 
20 5156 55/M 150 100 130 80 Good 
21 5244 31/M 140 90 120 80 Good 
22 5155 50/F 160 110 140 90 Fair 
23 6308 56/F 150 90 130 70 Good 
24 3245 55/F 145 90 120 80 Good 
25 4171 60/M 150 100 140 80 Fair 
26 5068 40/M 140 80 120 70 Good 
27 5114 55/M 160 100 160 90 Poor 
28 4624 53/F 150 100 130 70 Good 
29 1656 55/F 145 90 120 80 Good 
30 7616 52/F 170 100 140 90 Fair 
31 1152 60/F 150 100 130 80 Good 
32 1713 50/F 180 100 170 100 Poor 
33 9147 35/M 145 100 120 80 Good 
34 9033 58/M 150 110 120 80 Good 
35 5157 50/M 150 110 120 80 Good 
36 2413 47/F 140 100 130 70 Good 
37 5275 49/F 150 100 120 80 Good 
38 6642 55/M 150 100 130 80 Good 
39 1659 50/F 140 100 120 70 Good 
40 387 54/M 150 95 130 90 Fair 
 
             SBP – Systolic Blood Pressure               DBP – Diastolic Blood Pressure 
  
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 DISCUSSION 
       Hypertension also known as high blood pressure, is a long term medical 
condition, High blood pressure is classified as either primary or secondary .about 90-
95% of cases are primary , defined  as high blood pressure due to non specific 
lifestyle and genetic factors. 
    Uratha  pitham  is one among the pitha disease described by in his Yugi Munivar 
Vaidhiya chinthamani 800.The classical clinical features are early morning Head 
ache, Fatigue,Giddiness,Palpitation,Insomnia  and Visual disturbances . 
       Symptomatically the Uratha pitham are mostly similar to that symtoms of 
Hypertension. 
      Prevalence of  this disease is higher among Indians due to sedentary life 
style,Food habits and Hereditary. It is estimated that globally. 
    The patients  were  examined based on Siddha  and  as well as Modern aspects. The 
results obtained from their studies were discussed below for better conclusion. 
        The medicine puthina theeneer was administerd – 15-30ml  bds  for 48 days. 
     40 patients were treated in the outpatient  Department of Pothu Maruthuvam, 
Government Siddha Medical College, attached to Arignar Anna Hospital, 
Arumbakkam, Chennai -106. The time duration  for  treatment  was 48  days  and  all 
necessary  investigations were carried  out  to  all  patients  and    medicine  was  
given  and  followed  up regularly  in the OP department once in 7 days. 
 
.1.Drug authentication 
      The  fresh  samples  of  Puthina leaves  are  authenticated  by the    Botanist ,dept 
of Botany  from  Govt  Siddha  Medical  College, Chennai. 
2. Physicochemical  analysis 
          As per physiochemical analysis study on puthina theeneer contains Volatile 
matter-0.038%then Total solids-Nil and Specific gravity-1.000PH value(10%)-8.37. 
 
3.IAEC (Institutional Animal Ethics Committee) 
     All the protocols and the experiments conducted  in  strict  compliance according 
to ethical principles and guidelines provided by committee for the purpose of control 
and supervision of experiments  on Animals (CPCSEA). The animal experimental 
protocol was approved by the IAEC of Sathyabama University, Chennai. 
 
4. ACUTE TOXICITY STUDY 
 
    Acute toxicity study of the study drug Pudhina Theeneer was carried out as per 
OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. 
Acute toxicity study will be carried out in accordance with OECD guideline 423 1. 
The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Pudhina Theeneer. 
 
SUB-ACUTE TOXICITY STUDY 
     Sub-acute toxicity study was carried out as per OECD guidelines Guideline-407 2. 
The dose utilized for evaluation of Sub-acute toxicity study is about 0.1 ml for low 
and 0.2 ml for high dose as derived from the acute toxicity study. 
 
Hematological analysis 
      Blood samples were analyzed using established procedures and automated Bayer 
Hematology analyzer. 
 
Histopathological evaluation 
       Histological examinations were performed on the preserved tissues with 
particular emphasis on those which showed gross pathological changes. 
Toxicity Evaluation  of  Puthina theeneer  by Acute toxicity- OECD 423 and Sub-
Acute  repeated  dose oral toxicity study - OECD 407  in rats has been approved by 
the IAEC of Sathyabama University,Chennai.  IAEC Approval No: 
SU/CLATR/IAEC/IV/022/2016. 
 
Statistical analysis 
       The statistical analysis was carried by one way ANOVA (GRAPH PAD PRISM 
5 computer program). Results were expressed as mean ± standard error .A statistical 
comparison was carried out using the Dunnet’s test for the control and treatment 
group. 
 
  
5.Pharmacological study 
      The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. Pharmacological 
Evaluation of Puthina theeneer in Renal artery ligation induced Hypertension in Rats. 
IAEC Approval No: SU/CLATR/IAEC/053/016. 
 
6. Bio-Chemical Analysis 
    The Bio-chemical analysis  of  Puthina theeneer contains  Potassium, 
calcium,Reducing sugar and Alkaloids. 
 
7. Institutional Ethics Committee (IEC) 
    The  study  was  approved  by  Institutional  Ethics  Committee (IEC)  and the 
approval number  is  GSMC-CH-ME-4/2015/001. It  was  registered  in  Clinical  
Trials  Registry – India (CTRI) and  the  reference number  is  REF/2016/12/012947. 
 
8. Clinical study 
.     All  the  patients  were  treated  with the trial drug PUTHINA THEENEER  for  
an  average of 48 days. Blood and Urine Investigations were  taken  before and  after 
treatment Blood  and  urine were once again  tested  after  the completion of  
treatment. 
 
 
AGE DISTRIBUTION 
      Out of 40 patients, majority of the cases that is 23(57.5%) were in 51-60 years age 
group, 32.5% were in 41-50 years age group 10% of cases were in 30-40 years age 
group. 
 
 
SEX DISTRIBUTION 
   Out of 40 patients, majority of the cases that is 24(60%) were female and minority 
of the cases that is 16(40%) were male. 
  
THINAI 
   Out of 40 patients, 27(67.5%) comes under Marutham and 13(32.5%) comes under 
Neithal. 
 
SEASONAL DISTRIBUTION 
   As per Tamil seasonal classification highest incidence of 37.5% (15) of cases were 
noted in Koothir kaalam, 25% (10) cases were noted in pinpani kaalam, 17.5% (7) of 
cases were noted in Munpani kaalam, 12.5% (5) of cases were noted in Kaar kaalam, 
5% (2) of cases were noted in Mudhuvenil kaalam and 2.5 (1) of cases were noted in 
Elavenil kaalam. 
 
MUKKUTRAM 
IN  VATHAM 
        Pranan affected 7(17.5%), Viyanan affected in all patients (100%), Koorman 
affected 13% and Devathathan affected in 17 patients (42.5.%). 
IN PITHAM 
      Pranan affected 7(17.5%), Viyanan affected in all patients (100%), Koorman 
affected 13% and Devathathan affected in 17 patients (42.5.%) 
IN   KABAM 
      Out of 40 Patients, Avalamagam affected in 6 (15%) patients, Santhigam affected 
in 9 (22.5%) patients. 
EZHU UDAL THATHUKAL 
          Out  of  40  patients, Saram  and  Seneer affected  in all  patients and enbu were 
affected in 5. 
ENN VAGAI THERVUGAL 
        Vizhi  were  affected in 5 patients, Naadi  affected  in  all  patient. 
  
NAADI 
         26  of  cases  had  Vathapitham  Naadi, 7  of  cases  had  pitha Vatham, 5  of  
cases had  Vatham, each 1  of cases  had  kaba  pitham  and  kaba  vatham. 
 
NEIKURI 
       Out of 40 patients, 30 patients   had Vatha Neer, 10  had  Pitha  Neer. 
9.Bio-statistical Analysis 
          Since, the  p  value  is  highly significant ( p<0.001) in  all  signs  and  
symptoms  there  is  significant  reducing  of  signs  and  symptoms  among  the  
patients  for  the treatment  of  Uratha pitham(Hypertension). Hence, it  is  concluded  
that  the  treatment  was effective and significant. 
CLINICAL PROGRESS 
        Out of 40 patients, 17 patients  were affected Insomnia, 7 patients were affected 
Giddiness, 3 patient affected Head ache, 4 patients affected palpitation and 9 had  no 
symptoms 
Insomnia were affected in 21  patients before treatment and after treatment it was 
improved in 10  Giddiness were affected 15  patients in before treatment and after 
treatment it was improved in 7  patients, Head ache were affected 3  patients in before 
treatment and after treatment, it was improve  patients. Palpitation is were affected 6  
patients in before treatment and after treatment it was improved 1  patient 
.EFFECT ON BLOOD PRESSURE 
        Out of the 40 patients, Mild affected patients 10  in before treatment and after 
treatment 29  patients were improved and moderate affected patients 28  in before 
treatment and after treatment 14  were improved. 
GRADING OF RESULTS 
                     Out of 40 patients, 29  shows good result, 8 cases  shows 
              moderate results, 3 cases shows poor result. 
 
  
 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
 
 
 
 SUMMARY 
• The clinical study on URATHA PITHAM  was carried out in Post 
Graduate department of Pothu Maruthuvam, Government Siddha Medical College, 
attached to Arignar Anna Hospital, Chennai –106 during the period  of 2014-2017. 
• The clinical and pathological assessment was carried based on both Siddha 
and modern  aspects.I had selected 40 patients were treated in the outpatient 
department. 
• All the 40 patients were treated with puthina theeneer-15-30ml bd with water. 
The duration of    the  treatment  fixed as 48 days. The clinical responses  were 
assessing daily for all the patients. 
The results obtained from the studies are summarized below: 
• The incidence of the disease was found 30-60 age group. The maximum 
number of cases was observed in Pitha kaalam (34-66 years and 8 months). 
• Among dietary and personal habits, people had mixed diet, smoker, alcoholic 
and tobacco users were more incidence of the disease. Middle and High  socio-
economic status peoples were more affected. 
• Majority of cases comes under Marutham   Thinai. and minority of cases 
comes under Neithal.  Based on mukkutram, In Vatham, piranan, Koorman,  
devathatthan, In Pitham,sathagam, Alosagam and In Kabam, Avalambakam were 
affected in all  patients. 
• In Ezhuudalthathukal, Saaram, senneer was affected in all patients,and      
enbu  was affected in few patients  In Envagaithervugal, Vizhi  were affected in all 
patients. 
• Most of the patients had Vaadha Pitham and PithaVatha naadi. 
• The clinical trial shows that there is significant improvement in the clinical 
manifestation of Uratha pitham. 
• The pharmacological studies reveal that trial drugs had well anti hypertensive 
effect in rats. The toxicity study revealed that were no signs of toxicity no alteration 
in bio chemical parameters and histopathology study. 
• The bio-statistical report of the clinical trial shows significant result. 
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CONCLUSION 
 
 
 
 
 
 
 
 
 CONCLUSION 
        Uratha   pitham is  primarily  due  to  the  derangement  of   Pitham  and  
Vatham,  The taste  of   the trial drug  Puthina  theeneer  has  karppu  and  kaippu ,So  
the  Deranged   PITHAM  is  neutralised  by  the  trial drug on  ethirmarai  basis. 
• Toxicological  studies  revealed  no  toxicity  in  animal  model, so  the  
Puthina  theeneer   is safe  for  administration  of  patients  with  Uratha  
pitham(Hypertension) disease. 
• In   Pharmacological   studies, it  is  evident  that  the  trial medicine  has 
significant  Anti hypertensive activity. 
• In clinical study, the trial medicine gave maximum relief   from  the  
symptoms   of  Uratha  pitham. 
• No adverse effect   reported  during  the  course  of the  treatment. 
• The  trial  drug   Pudhina   theeneer  prepation   is  easier  more over the cost 
of the drug is economic one. 
• As per study the Pudhina theeneer very effective for the treatment of Uratha 
pitham(Hypertension). 
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Project Report on Toxicity Profiling of Pudhina Theeneer 
 
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Pudhina Theeneer was carried out as per 
OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. 
 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the study.  
The animals were housed in poly propylene cages and were kept in well ventilated 
with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle were 
maintained .Room temperature was maintained between 22 + 20 Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 423 1. 
The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Pudhina Theeneer. 
IAEC SU/CLATR/IAEC/IV/022/2016 
 
Name Dr. P. Kavitha 
IAEC SU/CLATR/IAEC/IV/022/2016 
Name of the Formulation Pudhina Theeneer 
Abbreviation PT 
  
 
 
Animal Grouping 
   One group consist of 6 female rats were used for this study. The dose utilized for 
evaluation of acute toxicity study is about 1.25 ml per rat which was ten times higher 
than the normal human therapeutic dose (30ml per day) 
 
Animal Grouping 
GROUP I : Animals received Test drug 1.25 ml (p.o) 
    The animals were fasted overnight (12- 16 hrs) with free access to water. The study 
was conducted with single oral administration of study drugPudhina Theeneer 1.25 
ml (p.o). The animals were observed continuously for first 72 h and then 14 days for 
emerging signs of behavioral changes, body weight changes and for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 24 h 
and observed periodically for the next 14 days.  Observation includes the change in 
skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention. 
Body weight was recorded periodically. At the end of the experiment all animals were 
subjected for gross necropsy and observed for pathological changes. 
 
SUB-ACUTE TOXICITY STUDY 
    Sub-acute toxicity study was carried out as per OECD guidelines Guideline-407 2. 
The dose utilized for evaluation of Sub-acute toxicity study is about 0.1 ml for low 
and 0.2 ml for high dose as derived from the acute toxicity study. 
 
Animals 
    Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2o Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and  
 water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
 
    The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC SU/CLATR/IAEC/IV/022/2016 
 
 
Animal Grouping 
   Animals were divided into three groups of 06 animals each consist of 3 male and 3 
female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o) 
GROUP II :Animals received low dose of test drug 0.1 ml (p.o) 
GROUP III :Animals received high dose of test drug 0.2 ml (p.o) 
The animals were randomly divided into control group and drug treated groups for 
two different doses viz. low dose (0.1 ml) and high dose (0.2 ml) per rat. 
 
The animals were administrated with the study drug once daily for 28 days. The 
animals in group I (control group) received normal saline 5 ml/kg b.w. The animals in 
group II received low dose of Pudhina Theeneer 0.1 ml(p.o) and group III received 
high dose of Pudhina Theeneer 0.2 ml (p.o). 
 
   The rats were weighed periodically and observed for signs of toxicity pertain to 
C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28th day, the animals were fasted for overnight 
with free access to water. On 29th day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
    The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
 
  
Hematological analysis 
 
    Blood samples were analyzed using established procedures and automated Bayer 
Hematology analyzer. Parameters evaluated include Packed Cell Volume (PCV), Red 
Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes. 
 
Biochemical analysis3 
    Serum samples were analyzed for High Density Lipoprotein (HDL), Low density 
Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides (TGL), 
Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total Protein, 
Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino Transaminase 
(ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer model BS 120. 
 
Histopathological evaluation4 
      Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes and 
ovary. Histological slides of organs were made and observed under the microscope.  
The pathological observations of cross section of these organs were performed on 
gross and microscopic bases. Histological examinations were performed on the 
preserved tissues with particular emphasis on those which showed gross pathological 
changes. 
 
Statistical analysis 
  The statistical analysis was carried by one way ANOVA (GRAPH PAD PRISM 5 
computer program). Results were expressed as mean ± standard error .A statistical 
comparison was carried out using the Dunnet’s test for the control and treatment 
group. 
 
 
 
 Methodology 
      Rats of control and treatment group were allowed to explore to open field on 
clean and sterile cage with blotting paper. The collected pellets were analyzed for 
consistency, color, Shape, Presence of blood cells etc. 
 
 
Acute Toxicity Study 
Analysis Group I 
Consistency Soft 
Shape Round ended 
Colour Greenish 
Mucous Shedding Absence 
Blood Cells Absent 
Signs of Infection None Observed 
 
Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Soft 
Shape Oblong Round ended Round ended 
Colour 
Brownish 
green Greenish Greenish 
Mucous Shedding Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of Infection 
None 
Observed 
None 
Observed 
None 
Observed 
 
             Muscle Grip Strength Analysis 
             Methodology 
     The grip strength test is a simple non-invasive method designed to evaluate rat 
muscle force in vivo. Rats of control and drug treatedgroup was allowed to hold the 
pull bar with both the hind limbs firmly then the animal was gently pulled back with 
the tail until the animal lost the grip toward the bar. The procedure was repeated  to  
get the average value. Muscle grip ness of the drug treated group was compared to 
that of the control rat to ensure the change in coordination. 
 
 
 Metabolic Cage for Urine Collection 
     Rat of control and treatment group was placed individually in metabolic cage with 
free access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap 
the fecal pellet mixed with urine sample. The collected urine sample was subjected to 
analysis with respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
 
RESULTS 
           Assessment of clinical signs in rats treated with Pudhina Theeneer on 
                                         Acute toxicity study 
 
Parameter Group I 
Clinical Signs Parameters 
for the duration of 14 
days 
Test Drug 1.25 
ml / rat 
Number of animals 
observed 6 Female 
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
Touch Response Normal 
Response to Sound 
Normal 
Response 
Response to Light 
Normal 
Response 
Mobility 
Normal 
Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and 
Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis 
No 
Abnormality 
Urine Colour Pale yellowish 
Urine Ph 6 
Urine –Glucose Absence 
Urine –Ketones Absence 
Urine- Bilirubin Absence 
Urine-Blood  Cells Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
                  Quantitative data on the body weight of rats treated with 
                              Pudhina  Theeneer in Acute toxicity study 
 
Group I 
Before Treatment 
Weight in Gms 
After Treatment 
Weight in Gms 
Mean 
177.5 181.2 
Std. Deviation 
5.32 4.956 
Std. Error 
2.172 2.023 
 
         Values are mean ± S.D (n = 6 per group). Control and treatment group 
       were   compared statistically using one way ANOVA followed by Dunnett’s test. 
           Assessment of clinical signs in rats treated with Pudhina Theeneer on 
                                     Sub-   Acute toxicity study 
 
Clinical Signs Parameters 
for the duration of 28 
days Control 
Test 
Drug 0.1 
ml 
Test 
Drug 0.2 
ml 
Number of animals 
observed 
3 Male and 3 
Female 
3 Male 
and 3 
Female 
3 Male 
and 3 
Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Absence 
Touch Response Normal Normal Normal 
Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Respons
e 
Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Respons
e 
  
 
Effect of Pudhina Theeneer on Body weight of Rats in Sub-acute toxicity study 
     Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control 
and treatment groups were compared statistically using one way ANOVA followed 
by Dunnett’s test. 
 
 
Quantitative data on the food and water intake of rats treated with       Pudhina 
Theeneer for 28 days in Sub-acute toxicity study 
 
 
GROUP I Food intake Water intake 
Mean 17.33 33.92 
Std. Deviation 3.82 2.727 
Std. Error 1.91 1.363 
GROUP II Food intake Water intake 
Mean 19.83 31.25 
Std. Deviation 3.737 2.47 
Std. Error 1.868 1.235 
 
 
 
 
 
             Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
                        Low Power Magnification 10X 
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          Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
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                High Power Magnification 40X 
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         Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
             Low Power Magnification 10X 
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           Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
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            Histopathology of Lung (Female Rat) in Sub-acute toxicity Study 
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              Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
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           Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
                  Low Power Magnification 10X 
  
             GROUP I  GROUP II    GROUP III 
 
               High Power Magnification 40X 
  
              GROUP I              GROUP II   GROUP III 
             Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
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         Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
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             Histopathology of Brain (Male Rat) in Sub-acute toxicity Study 
            Low Power Magnification 10X 
  
           GROUP I                   GROUP II   GROUP III 
 
                 High Power Magnification 40X 
   
          GROUP I              GROUP II            GROUP III 
             Histopathology of Heart (Male Rat) in Sub-acute toxicity Study 
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              Histopathology of Kidney (Male Rat) in Sub-acute toxicity Study 
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Reference 
1. OECD Guideline for testing of Chemicals (2001) Guideline 423: Acute Oral 
Toxicity-Acute Toxic Class Method. 
2. OECD Guide lines 407 for testing of chemicals. Repeated dose 28-Day Oral 
Toxicity Study in Rodents. 2008: pp 2- 8. 
3. Jain N, Sharma P, Sharma N, Joshi S C. Haemato-biochemical profile 
following sub acute toxicity of malathion in male albino rats. Pharmacologyonline. 
2009;2:500–506. 
4. Suvarna, S.K., C.Layton and J.D. Bancroft. 2013. Bancroft’s theory and 
practice of histological techniques. 7th edn, Churchill Livingstone, London 
 
 
  
 
 
 
 
 
 
 Pharmacological Evaluation of PudhinaTheeneer in Renal artery ligation 
induced hypertension in rats. 
Name: Dr.P.Kavitha 
IAEC: SU/CLATR/IEAC/VII/053/2016 
Animals 
      Healthy adult Wistar albino male rats weighing between 200-220 g were used for 
the study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit . A 12 light / dark cycle were 
maintained .Room temperature was maintained between 22 + 2o Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study.The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC: SU/CLATR/IEAC/VII/053/2016 
Experimental Methodology 
     The animals were grouped into four groups of 6 animals each. Group I (Sham 
Operated group) –Surgically exposed renal artery without ligation. Group II – Rats 
underwent surgical renal artery ligation served as hypertension control. Group III – 
Rats underwent surgical renal artery ligation and treated with low dose of 
PudhinaThaneer0.1 ml(p.o). Group IV – Rats underwent surgical renal artery ligation 
and treated with low dose of PudhinaThaneer02 ml(p.o). 
Study Protocol 
     All the experimental animal belongs to group III and IV were treated with 0.1 and 
0.2 ml of PudhinaThaneerorally for the period of four weeks followed by this on the 
29th day of experiment the renal artery was occluded for 6 h (ischemia) following the 
surgery; the animals than anesthetized by intraperitoneal injection of 30–40 mg/kg 
pentobarbital sodium. To measure hemodynamic parameters, the cannula in the 
carotid artery was connected to a pressure transducer (ML224-Quad Bridge 
Amplifier, ADInstrument) and Powerlab data acquisition system (8/30 LabChart, 
ADInstrument). For administration of the test compound, a jugular vein was 
cannulated. After 6 h the renal arterial artery ligation was removed (reperfusion). This  
 
 leads to a rise in blood pressure as a consequence of elevated plasma renin level. 
Within 15 min a stable hypertension is achieved. The test substance was then 
administered by intravenous injection at doses of 0.1 and 0.2 ml to renal hypertensive 
and normotensive rats. Hemodynamic parameters were monitored continuously. After 
measurement of blood pressure, the left kidney was removed and stores at 10% 
formalin saline for histopathological analysis. 
Induction of hypertension 
    The hypertension was induced in experimental animals by ligation of left renal 
artery. Rats were anaesthetised by 30–40 mg/kg pentobarbital sodium.  A 3 cm 
retroperitoneal flank incision was done. The left kidney was exposed and the renal 
artery were carefully separated free of the renal vein. The renal artery was then 
ligated by sterile surgical silk thread. 
Measurement of Blood pressure 
    Systolic blood pressures will be measured in the middle two days of every week for 
four using the tail-cuff method. The average of five readings was then recorded. 
Duration of the study was 4 weeks. 
 
     Histopathology of Rat Kidney (H&E) Staining 
           Low Power Magnification 10 X 
Control Group Treatment group – High dose of PudhinaTheeneer 
 
 
       Histopathology of Rat Kidney (H&E) Staining 
      HighPower Magnification 40 X  Control Group 
 
 
 
 
      Histopathology of Rat Kidney (H&E) Staining 
        HighPower Magnification 40 X 
           Control Group                             Renal artery Ligation group 
 
           Treatment group – Low dose of PudhinaTheeneer 
 
            Treatment group – High dose of PudhinaTheeneer 
 
 
 
Pathology report 
• Sample belongs to sham operated control group rat reveals the presence of 
normal glomerulus (G) surrounded by a narrow capsular space and the parietal layer 
of Bowman's capsule. Epithelial lining on proximal convoluted tubule appears 
normal. Lumen of distal convolutes tubule and collecting duct was normal. No signs 
of infiltration or degeneration were observed in this group 
• Microscopic observation of kidney belongs to renal artery ligated group 
reveals the presence of mild glomerular necrosis, protein cast, degeneration of tubular 
epithelium, necrosis in tubular epithelium and congestion of blood vessels. 
• Sample belongs to group III rats projects occasional evidence of protein cast 
and restored tubular epithelium preservation with marked evidence of inflammatory 
changes. 
• Increased bowman’s space with regular arrangement of tubular epithelium and 
very minimal cast were observed with dominant evidence of blood vessel congestion 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
 
Preparation of Sodium Carbonate extract: 
 
    2 gm of the sample drug is mixed 5 gm of Sodium carbonate and takenin a 100 ml 
beaker and 20 ml of distilled water is added. The solution is boiled for 10 minutes, 
cooled and then filtered. The filtrate is called sodium carbonate extract. 
 
S.No EXPERIMENT OBSERVATIO
N 
INFERENCE 
I TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared 
extractis taken in a test tube. To 
this add2ml of 4% Ammonium 
oxalatesolution. 
Absence of 
White 
Precipitate 
Absent 
b 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off. 
Then2ml barium chloride 
solution isadded. 
Absence of 
White 
Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with 
dilutenitric acid till the 
effervescenceceases. Then 2ml 
of silver nitratesolution is added. 
white precipitate 
obtained 
Absent 
3 Test for Phosphate 
2ml of the extract is treatedwith 
2 ml of Ammoniummolybdate 
solution and 2ml ofconcentrated 
nitric acid. 
 
Yellow 
precipitate 
Obtained 
Absent 
4 Test for Carbonate: 
2ml of the extract is treatedwith 
2ml of magnesiumsulphate 
solution. 
Absence of 
white 
Precipitate 
Absent 
5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated Hcl. 
Absence of 
Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is 
heatedwith copper turnings 
andconcentrated sulphuric 
acidand viewed the test 
tubevertically down. 
Absence of 
reddish 
brown gas. 
Absent 
 
7a Test for Fluoride and oxalate 
2ml of the extract is added 
with2ml of dilute acetic acid 
and2ml of calcium 
chloridesolution and heated. 
Absence of 
white 
Precipitate 
Absent 
B 5 drops of clear solution isadded 
with 2ml of diluted sulphuric 
KMNO4 
solution 
Absent 
acid and slightlywarmed to this, 
1 ml of dilutepotassium 
permanganatesolution is added. 
Discolourisation 
obtained 
8 Test for Nitrite 
3 drops of the extract is placedon 
a filter paper. On that, 2 drops of 
Acetic Acid and 2drops of 
Benzidine solution isplaced. 
Absence of 
yellowish red 
colour 
Absent 
9 Test for Borate 
2 pinches of the substance 
ismade into paste by 
usingSulphuric acid and 
Alcohol(95%) and introduced 
into theblue flame. 
Absence of 
Green 
tinged flame 
Absent 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is addedwith 2 
ml of Potassium iodidesolution. 
Absence of 
Yellow 
Precipitate 
Absent 
11a Test for Copper 
One pinch of substance ismade 
into paste withconcentrated 
Hydrochloric acidin a watch 
glass and introducedinto the non 
luminous part ofthe flame. 
Absence of 
Bluish 
green coloured 
flame. 
Absent 
B 2ml of the extract is added 
withexcess of Ammonia solution 
Absence of deep 
Blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. 
SodiumHydroxide solution is 
added indrops to excess 
Absence of 
White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml 
ofAmmonium 
ThiocyanateSolution is added. 
Absence of 
Blood 
red colour 
Absent 
b To the 2 ml of extract, 2 ml 
ofAmmonium 
Thiocyanatesolution and 2 ml 
ofconcentrated Nitric Acid 
isadded. 
Absence of 
Blood red colour 
obtained 
Absent 
14 Test for Zinc 
To the 2 ml of extract 
SodiumHydroxide solution is 
added indrops to excess. 
Absence of 
White 
precipitate. 
Absent 
15 Test for Calcium 
2 ml of the extract is addedwith 2 
ml of 4% AmmoniumOxalate 
solution. 
Absence of 
White 
precipitate. 
Absent 
16 Test for Magnesium 
2mlof extract, SodiumHydroxide 
solution is added indrops to 
excess. 
Absence of 
White 
precipitate. 
Absent 
17 Test for Ammonium 
2ml of extract few ml 
Absence of 
Reddish brown 
Absent 
ofNessler’s Reagent and 
excessof Sodium Hydroxide 
solutionare added. 
precipitate 
18 Test for Potassium 
A pinch of substance is 
treatedwith 2 ml of Sodium 
Nitritesolution and then treated 
with 2ml of Cobal Nitrate in 
30%glacial Acetic acid. 
Presence of 
Yellow 
precipitate 
 
Present 
19 Test for Sodium 
2 pinches of the substance 
ismade into paste by 
usingHydrochloric acid 
andintroduced into the blue 
flame. 
Absence of 
Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treatedwith 
2 ml of SodiumHydroxide 
solution. 
Absence of 
yellow 
precipitate 
Absent 
21 Test for Arsenic 
2 ml of extract is treated with 
2ml of silver Nitrate solution. 
Absence of 
Yellow 
precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated 
withweak iodine solution 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts 
qualitativesolution is taken in a 
test tubeand allowed to boil for 
2minutes and added 10 drops 
ofthe extract and again boiled 
for2 minutes. The colour 
changesare noted. 
Absence of 
Green colour 
Present 
24 Test of the alkaloids 
2ml of the extract is treatedwith 
2ml of potassium lodidesolution. 
Presence of 
Red colour 
Alkaloids 
present 
25 Test of the proteins 
2ml of the extract is treated with 
2ml of 5% NaOH,mixwell and 
add 2 drops of coppersulphate 
solution. 
Absence of 
Violet colour 
Absent 
 
          RESULTS: 
             The given sample(Puthina theeneer) contains 
Potassium 
Alkaloids 
Reducing sugar. 
  
 
 
 
  
 
 
 
                            CLINICAL PROGNOSIS 
Treatment for Hypertension: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
 
S. 
No 
Symptoms Before Treatment After Treatment 
n% n% 
1. Insomnia 21(52.5) 10(25)** 
2. Giddiness 15(37.5) 7(17.5)** 
3. Head ache 3(7.5) 0(0)* 
4. Palpitation 6(15) 1(2.5)** 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
 
Inference:  
Since the p value is significant in all symptoms. So there is significant 
reducing of   symptoms among the patients for the treatment of Hypertension. Hence 
it is concluded that the treatment was effective and significant.  
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CLINICAL STUDY ON “PUTHINA THEENEER” IN THE TREATMENT OF 
“URATHA PITHAM”(HYPERTENSION) 
 
 INFORMED CONSENT FORM 
 
“I have read the foregoing information. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my 
satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have 
the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
 
 
Signature of the Guide:   Signature   of  the  Investigator:   
 
 
 
 
 
 
«ÃÍ º¢ò¾ ÁÕòÐÅì ¸øæ¡¢, ¦ºý¨É-106 
«È¢»÷ «ñ½¡ ÁÕòÐÅÁ¨É, ¦ºý¨É 
                      உரuni0BA4_uni0BCDத பிuni0BA4_uni0BCDதuni0BAE_uni0BCD  §¿¡öì¸¡É º¢ò¾ ÁÕó¾¢ý (uni0BAA_uni0BC1தினாuni0BAA_uni0BC1uni0BAA_uni0BC1uni0BAA_uni0BC1  தந    ) 
À¡¢¸¡¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
´ôÒ¾ø ÀÊÅõ 
 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
    ¿¡ý þó¾ ¬ö× ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ ÒÃ¢Ôõ 
Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ‾Ú¾¢ÂÇ¢ì¸¢§Èý. 
§¾¾¢:       ¨¸¦Â¡ôÀõ: 
þ¼õ:       ¦ÀÂ÷     : 
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
±ýÉ¢¼õ þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨È ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ‾¼ø þÂì¸ò¨¾ ¸ñ¸¡½¢ì¸×õ, 
«¾¨ÉÀ¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢ ¾¢Õô¾¢ 
«Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø, ±ô¦À¡ØÐ 
§ÅñÎÁ¡É¡Öõ þó¾ ¬öÅ¢Ä¢ÕóÐ ±ý¨É Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ‾Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ‾Ã¢¨Á¨Âì 
¦¸¡ñÎ  உரuni0BA4_uni0BCDத பிuni0BA4_uni0BCDதuni0BAE_uni0BCD  §¿¡öì¸¡É uni0BAA_uni0BC1தினாuni0BAA_uni0BC1uni0BAA_uni0BC1uni0BAA_uni0BC1  தந     ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò 
¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ‾ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 
§¾¾¢ :        ¨¸¦Â¡ôÀõ : 
þ¼õ :        ¦ÀÂ÷          : 
 
§¾¾¢  :        º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ : 
þ¼õ  :       ¦ÀÂ÷     :                                                                  
‾È×Ó¨È : 
 
Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ :  
     
 
GOVT.SIDDHA M 
EDICAL COLLEGE, 
CHENNAI-106 
 POST GRADUATE DEPARTMENT  
BRANCH –I MARUTHUVAM 
CASE SHEET PROFORMA FOR URATHA PITHAM 
Duration: 2014-2017 
 
OP No / IP No. :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
                                                                                  Diagnosis                   : 
Address                       :       
                                                                                                                                                                                        
1. Complaints and duration  : 
 
 
 
 
2. History of present illness  : 
 
 
 
 
3. History of past illness  : 
4. Personal history   : 
 
                                                                                   
 
5. Occupational history  : 
 
  
6. Menstrual history   : 
 
 
 
7. Personal Habits   :Veg/nonveg/smoker/Alcocoholic/Tobacco  
                                                                                                                     chewer 
 
 
8. Family History   : 
 
 
GENERAL EXAMINATION  
Patient consciousness   : 
Body Built    : 
Nourishment    : 
Anaemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema    : 
Lymph adenopathy   : 
Vital Signs 
Body Temp    : 
Pulse     : 
Respiratory rate   : 
Blood Pressure   : 
Weight    : 
 
 
 
SIDDHA ASPECT  
NILAM 
Kurinchi  : 
Mullai   : 
Marutham  : 
Neithal  : 
Palai   : 
 
 
YAAKKAI(Udal) 
Vaatham  : 
Pittham  : 
Kabam   : 
Kalappu  : 
GUNAM 
Satthuvam  : 
Rajotham  : 
Thamasam  : 
 
 
PARUVA KALAM 
Kaar   : 
Koothir  : 
Munpani  : 
Pinpani  : 
Elavenil  : 
Muduenil  : 
 
 PORI/PULANGAL (SENSORY ORGANS) 
Mei –Sensation   : 
Vaai – Taste    : 
Kan – Vision     : 
Mooku - Smell   : 
Sevi – Hearing   : 
KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam    : 
Kaal-Kamanam   : 
Vaai-Vasanam   : 
Eruvaai- Visarkkam   : 
Karuvaai-Aanantham   : 
UTHKAAYA ATHAKAAYAM 
Puyam[forearm]   : 
Sayam[arm]    : 
Kaal[leg]    : 
Paaatham[feet]   : 
UYIR THATHUKKAL 
 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
 
 
 
B.PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirrasaga pitham  : 
Alosaga pitham  : 
 
C.KAPAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
 UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
Sukkilam/Suronitham  : 
ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
7.Moothiram 
a)Neer Kuri  : 
 b)Nei Kuri  : 
8.Naadi   : 
 
 
MALAM 
 Niram    : 
 Edai    : 
 Erugal    : 
 Elagal    : 
MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
   2.Neikuri 
MODERN ASPECT 
   Sytemic Examination  
 Inspection   : 
 Palpation   : 
 Percussion   : 
 Auscultation   : 
 Proctoscopy   : 
     Others Systems  
 Cardio Vascular System : 
 Respiratory system  : 
 Central nervous system :  
 Genito urinary system  : 
 
 
 
 
 
 
 
 
 
  
CLINICAL SIGN AND SYMPTOMS OF URATHA PITHAM 
SL.No
. 
Signs & 
Symtomps 
Before 
Treatmen
t 
After Treatment 
1. Insomnia   
7 
day
s 
 
14 
day
s 
 
21 
day
s 
 
28 
day
s 
 
35 
day
s 
 
42 
day
s 
 
49 
day
s 
2. Giddiness         
3. Palpitation         
4. Head ache         
5. Sweating         
6. Fatigue         
7. Visual 
disdurbanc
e 
        
 
  INVESTIGATION 
      1. BLOOD 
 TC 
 DC 
 ESR 
 Blood sugar 
 Blood urea 
 Serum cholesterol 
            Serum creatinine 
            Lipid profile  
      2. URINE 
 Albumin 
 Sugar 
 Deposits 
    5. DIGITAL EXAMINATION  
            ECG 
           Chest Xray 
 
    
 
DIFFERENTIAL DIAGNOSIS 
 
DIAGNOSIS 
 
TRIAL DRUG 
Dose: 
Anubanam : 
Duration of Treatment 
Pathiam (Do’s and Don’ts) 
Prognosis at the end of the Treatment. 
 
Medial Officr Signature:       HOD 
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